Introduction {#s1}
============

Cell differentiation is accompanied by polarization and segregation of membranes, cytoplasm, and organelles. A powerful mechanism to generate subcellular asymmetries used by eukaryotes and even prokaryotes is mRNA localization in combination with controlled protein translation (reviewed in [@bib44]). Long-range mRNA transport in most metazoans relies on the polarized cytoskeleton and the microtubule minus- and plus-end motor complexes. mRNA enrichment at microtubule minus-ends is aberrant in mutants that affect the dynein motor complex, while plus-end directed transport requires kinesin molecules (reviewed in [@bib6]; [@bib44])

Mechanistic dissection of several canonical localization examples showed that, mRNAs localize through *cis*-regulatory sequences, zipcodes, which are often present in the 3′UTR of the transcript (reviewed in [@bib32]) and zipcode-binding proteins that initiate the formation of transport competent ribonucleoproteins (RNPs) ([@bib19]; [@bib8]; [@bib14]; [@bib20]). mRNAs can also harbour two antagonizing localization signals that act consecutively in cells and direct mRNAs sequentially to opposing microtubule ends ([@bib25]; [@bib34]), suggesting that transport RNPs could be regulated. It has further been shown that some mRNA localization elements are active in several cell types suggesting that the mRNA transport machinery is widely expressed and mRNA localization elements function in a cell-type independent manner ([@bib37]; [@bib7]; [@bib54]; [@bib34]).

In addition to microtubule-based transport, some mRNAs can enrich by trapping to a localized anchoring activity ([@bib23]; [@bib53]) or by hitch-hiking along with a localization-competent mRNA ([@bib33]). Recent live-imaging studies revealed that the same mRNA can, depending on the cell type, use both diffusion and active transport mechanisms ([@bib47]). Furthermore, in vitro data showed that mRNA transport along microtubules can occur both uni- and bi-directionally, suggesting mRNAs can switch between processive and diffusive transport modes ([@bib55]).

mRNA localization is perhaps best characterized in the oocyte of *Drosophila melanogaster* (*D. melanogaster*) where localization of *oskar, bicoid*, and *gurken* is instrumental for setting up the embryonic axes ([@bib4]; [@bib57]; [@bib21]; [@bib46]). However, more recent work suggests that mRNA localization is not occurring only for few singular mRNAs but instead is a widespread cellular feature that affects a large proportion of expressed mRNAs ([@bib52]; [@bib5]; [@bib40]; [@bib68]; [@bib10]). How a cell distinguishes localized from ubiquitous transcripts and orchestrates transport of many mRNAs remains enigmatic. It is conceivable that each localized mRNA carries its own zipcode sequence that directs it to a specific subcellular location. However, despite wealth of data on co-localized transcripts, computational methods thus far fail to detect such signals in a reliable manner. Alternatively co-packaging of several mRNA species, only one of which carries specific localization signal, has been shown in at least two cases ([@bib39]; [@bib33]). It is also unclear to what extent the mRNA localization status is subject to tissue specific regulation.

Here, we describe a genome-wide image-based resource that unravels the global landscape of mRNA localization in the *Drosophila* ovary by combining stage-specific mRNA sequencing with systematic fluorescent in situ hybridizations (FISH) and imaging. The localized transcripts show characteristic gene level features, such as longer and highly conserved 3′UTRs, which clearly distinguish subcellular enriched from ubiquitous mRNAs. Comparing mRNA localizations across the sampled time-points showed that the localization status of the majority of mRNAs changes in the oocyte as oogenesis progresses. These changing localizations are not due to alternative gene expression since the germline cells of the *Drosophila* ovary show only little transcriptional change. Integrative analysis of ovary localization data together with similar data from embryos ([@bib40]) also revealed that mRNA localizations differ across cell types. Therefore, mRNA localization is widespread in cells and is highly regulated.

Results {#s2}
=======

Widespread mRNA localization in *Drosophila* ovaries {#s2-1}
----------------------------------------------------

To globally investigate post-transcriptional regulation through mRNA localization, we systematically probed and imaged the expression and subcellular distributions of mRNAs in egg-chambers mass isolated from *Drosophila* ovaries. We combined stage-specific mRNA sequencing (3Pseq and RNAseq) with genome-wide fluorescent in situ hybridization (FISH). RNA sequencing data, expression pattern annotations (using a hierarchical controlled vocabulary-<http://tomancak-srv1.mpi-cbg.de/cgi-bin-public/ovary_annotation_hierarchy.pl>) and images (representative 2D images and all original z-stacks) are collected in a publicly accessible database, the Dresden Ovary Table, DOT (<http://tomancak-srv1.mpi-cbg.de/DOT/main>) ([Figure 1---figure supplement 1A,B](#fig1s1){ref-type="fig"}). This genome-wide resource also integrates data on tissue-specific gene expression ([@bib61], [@bib62]) and subcellular mRNA localization ([@bib40]) in *Drosophila* embryos.

Based on our in situ hybridization screen, we identified 3475 mRNAs as being expressed and most of these mRNAs were also detectable by RNA sequencing. Both sequencing techniques were in good agreement with each other ([Figure 1A](#fig1){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}, [Figure 5---figure supplement 1A](#fig5s1){ref-type="fig"}). Of the expressed genes, 64% showed ubiquitous mRNA distribution in ovary cells throughout oogenesis (*ubiquitous*), but we also observed mRNA expressions restricted to subsets of cells (*cellular*) and mRNAs that asymmetrically localized in the cytoplasm (*subcellular*) or to the nuclei of cells (*nuclear*).10.7554/eLife.05003.003Figure 1.Summary of the fluorescent in situ hybridization (FISH) screen in ovaries.(**A**) Summary of key numbers of the screen. For each of the 6091 FISH experiments, we annotated the signal as no signal, ubiquitous, or specific. Specific and some ubiquitous signals were imaged. (**B**) Schematic of exemplary subcellular expression patterns. (**B′**) Exemplary subcellular expression patterns. In the syncytial early egg-chamber, 591 mRNAs are transported from the site of transcription in the nurse cells into the developing oocyte: mRNAs are either restricted to a cortical domain (*fwe*) or detectable in the entire ooplasm (*Imp*). mRNAs also simultaneously enriched in the oocyte portion of the syncytial egg-chamber and at the apical membrane of the somatic epithelial cells (*Shroom*). Five mRNAs were specifically excluded from the oocyte portion and enriched in the nurse cells (*Nacalpha*). Few mRNAs were enriched anterior in stage 2--7 oocytes (*mus209*). mRNAs showed ubiquitous granules in the cytoplasm (*CG17494*) or rarely ring-like staining patterns (*RpS6*, inset \[10 × 10 μm\] showing only the RNA channel). mRNAs enriched around the nucleus of the oocyte and/or the nurse cells (*msk*) varying from a ring around the entire nucleus to restricted localization in sub-areas of the perinuclear space (*spoon*). Apical enrichment (*CG43693*) or basal localization (*CG12171*) was detected in late epithelial somatic cells. Anterior and posterior RNA localization varied between diffuse (*fs(1)N, yemalpha*) and tight cortical enrichments (*Lcp65Ac, mus210*). (**C**) Distribution of subcellular localized mRNAs in subcategories. Note: mRNAs can appear in more than one subgroup. (**D**) GO-term enrichment analysis of ubiquitous, cellular, nuclear, and subcellular gene sets.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.003](10.7554/eLife.05003.003)10.7554/eLife.05003.004Figure 1---figure supplement 1.Experimental outline and database features.(**A**) Overview of the experimental procedure for transcriptome and genome-wide in situ hybridization experiments and evaluation. (**B**) Screenshot of the publicly available Dresden ovary table, DOT, and key search and download functions.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.004](10.7554/eLife.05003.004)10.7554/eLife.05003.005Figure 1---figure supplement 2.GO-term enrichment analysis for gene sets.GO-terms associated with ubiquitous, subcellular, cellular, nuclear, oocyte enriched, anterior and posterior gene sets. Shown is also analysis of all 'localization competent' mRNAs. Bar plots show the p-values for each GO-term calculated by the modified Fisher Exact test, which results in the EASE score p-value.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.005](10.7554/eLife.05003.005)

Subcellular mRNA localization affected 790 mRNAs (22%) but was limited to small number of subcellular domains ([Figure 1B--C](#fig1){ref-type="fig"}). The largest group was 591 mRNAs that were enriched in the oocyte portion of the syncytial egg-chamber during early oogenesis (*fwe, Imp, Shroom*). At this stage, the microtubule minus ends of the polarized microtubule cytoskeleton are also concentrated in the oocyte (reviewed in [@bib58]). At mid-oogenesis the oocyte establishes its own polarized microtubule cytoskeleton ([@bib58]) and at this stage, we observed 106 mRNAs enriched towards the anterior and 119 mRNAs enriched at the posterior pole. The quality of these localizations ranged from tight (*mus210*, *Lcp65Ac*) to diffuse association (*yemalpha, fs(1)N*) at the anterior-dorsal, the entire anterior or the posterior cortex. mRNAs were also detected in subcellular domains of the nurse (*msk, spoon*) and somatic epithelial cells (*CG43693, CG12171*). For few mRNAs, we observed previously unknown ovary accumulations, for example mRNAs in cytoplasmic granules (*CG17494*), depleted from the oocyte (*Nacalpha*), showing cortical enrichment (*Actn*), or forming ring-like structures (*CG14639*, [Figure 1B\'](#fig1){ref-type="fig"}, [Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}).

The 309 mRNAs (13%) of the cellular category were predominantly expressed in the somatic epithelium (follicle cells) and often restricted to a subset of epithelial cells at specific oogenesis stages ([Figure 2A,B](#fig2){ref-type="fig"}). 191 RNAs were detectable specifically in ovarian nuclei, mostly of the endocycling, polyploid nurse cells, but also in epithelial cells and in 29 cases in the oocyte nucleus ([Figure 2C,D](#fig2){ref-type="fig"}). The RNAs in ovarian nuclei were visible from stage 9 of oogenesis onwards and their localization changed appearance from stage 9 to 10 ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Nuclear patterns varied from ring-like signal to dispersed foci or widespread distribution in the nucleoplasm and were not linked to the chromosomal position of the genes ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). Precursors of micro RNAs and long non-coding RNAs also showed varying degrees of nuclear enrichments ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}).10.7554/eLife.05003.006Figure 2.Summary of cellular and nuclear expression patterns.(**A**,**C**) Exemplary FISH experiments for the cellular (**A**) and nuclear (**C**) expression sets. RNA is shown in green and the DNA (labelled with DAPI) is shown in magenta. Scale bars: 30 μm. (**A**) *tutl* is expressed in cap cells at the tip of the germarium, while *Ect3* mRNA is detectable in the somatic epithelial cells of the germarium. Several mRNAs are expressed in mosaic pattern, indicating cell cycle control in somatic epithelial cells (*His3.3A, Obp99a*) and in nurse cells (*His3.3A*). Expression in the anterior and posterior follicle cells is often seen simultaneously (*CG11275, CG11147, Nep2*). Some mRNAs were expressed only in anterior follicle cells that become migratory border cells (*Men-b*) or in posterior follicle cells (*CG9336*). *CG8303* is expressed in the somatic cells destined to become columnar epithelium. *aop* is exclusively seen in follicle cells that will give rise to the squamous epithelium and several mRNAs are specifically expressed here at later stages (*ImpL2, CG7997*). mRNAs are also expressed in cells forming the border of columnar and squamous epithelial cells (*inx2*). (**C**) Nuclei enrichments of RNAs in nurse cells varies from a ring-like expression (*CG11076*) to foci in a discrete area (*Dbp80*), widespread foci (*CG10962*), or nucleoplasm signal (*Rm62*). RNAs are also detectable in epithelial cell nuclei (*pip*) and for 28 RNAs also in the oocyte nucleus (e.g., *CG5819*). Greyscale image shows the respective RNA staining only in a zoomed-in view. (**B**) The cellular gene set was subcategorized according to the specific cellular expression pattern. Individual mRNAs can fall into several of these subgroups. (**D**) Instances of nuclear RNA enrichments in nurse cells, epithelial cells, and the oocyte.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.006](10.7554/eLife.05003.006)10.7554/eLife.05003.007Figure 2---figure supplement 1.FISH screen results and controls.(**A**) Estimate of false-positive/negative rate of the in situ screen using comparison with the independent transcriptomics data. A gene was classified as falsely positive if it was annotated as ubiquitous or specific by FISH but was not detectable by either 3Pseq or RNAseq at any time-point of oogenesis. In 20% of the experiments we failed to detect in situ signal ('no signal') although the transcript was detected at least at one time point by at least one deep sequencing method. These may represent false negative results, possibly due to non-functional RNA probes, however, we nevertheless included them in the downstream analysis in the no signal category. (**B**) mRNA enrichments in the somatic epithelial cells overlaying the oocyte (*CG14639*) and at the cortex of nurse cells (*Actn*). RNA signal shown in green. DNA, labelled with DAPI, is shown in magenta. Scale bar 30 μm. (**C**) *CG9609* and *Doa* mRNAs detected in the oocyte nucleus showing the enrichment over time at stages 9, 10A and 10B. At stage 9 only few small mRNA foci are visible, at stage 10 the mRNAs were enriched in proximity of the DNA in two large foci (see arrows). (**D**) Karyogram showing the chromosomal position of genes for nuclear, anterior, and posterior RNA localization classes. Neither nuclear RNA genes, which often appear in foci-like enrichments nor anterior or posterior class genes appear clustered on the chromosome. (**E**) Examples of FISH experiment detecting distributions of non-coding RNA (in green). While *pri-miRNA-318* is enriched in somatic epithelial cell nuclei, *pri-miRNA-303*, *pri-miRNA-31-b* and the long non-coding RNA *CR42862* are restricted to nuclei of the germline nurse cells. Scale bar 30 μm, DNA in magenta.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.007](10.7554/eLife.05003.007)

In summary, our screen revealed countless new instances of tissue-specific gene expression and mRNA localization in the ovary. The relatively low number of different subcellular localization sites allowed us to group mRNAs into subcellular localization gene-sets containing tens to hundreds of co-regulated genes.

Global features of localized mRNAs {#s2-2}
----------------------------------

The division of RNAs into gene sets enabled us to address whether genes within each class are functionally related ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Gene Ontology (GO) analysis showed that the subcellular gene set is distinct from the cellular and the nuclear gene sets. Consistent with their respective expression, cellular genes are enriched for epithelial development, lipid trafficking and cuticle formation, nuclear genes for RNA regulatory processes and the subcellular gene set for reproductive processes, cytoskeleton organization, and cell cycle regulation. Anterior and posterior gene sets differed: anterior genes were enriched for microtubule terms and, being localized in proximity to the meiotic oocyte nucleus, are additionally associated with chromosome and cell cycle regulation terms. The posterior mRNAs associated strongly with signalling, cell fate commitment, and membrane organization terms. The GO analysis suggests that mRNAs that co-localize in the cytoplasm are functionally related.

We next asked whether the proteins encoded by the mRNAs show physical interactions. To this end, we analysed the protein interaction data (mentha interactome database \[[@bib11]\]), which revealed that proteins of the posterior gene set participate in significantly more protein--protein interactions than of the anterior gene set ([Figure 3B](#fig3){ref-type="fig"}). This suggests that the close proximity of their transcripts in the cell could be of functional importance. The gene sets defined by our ovary screen also maintained distinct expression patterns during embryogenesis. Genes of the subcellular sets are enriched among genes expressed in the central nervous system and epithelia, suggesting an interesting relatedness of these polarized tissues ([Figure 3A](#fig3){ref-type="fig"}, [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Thus, gene sets defined by ovary expression are co-regulated also beyond oogenesis.10.7554/eLife.05003.008Figure 3.Localized mRNAs show gene set specific features.(**A**) Linear hierarchy plot ([@bib62]) showing stage- and tissue-specific re-expression of the ovary gene sets in embryogenesis. (**B**) Protein interaction analysis per gene set revealed that posterior genes, but not anterior genes, share significantly more protein--protein interactions than would be expected by chance. (**C**) Boxplot showing the median mRNA expression level is significantly higher in the posterior gene set compared to anterior mRNAs (**C′**: Kolmogorov--Smirnov p-value: 3.9e-06). Shown are 3Pseq quantifications from late ovary mRNA (for early, full ovaries and early embryogenesis see [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). For description of gene sets see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. (**D**--**E**) Distributions of median 3′UTR length (**D**) and conservation of the 3′UTR sequence (**E**, across 24 *Drosophila* species) for gene sets. (**D′**--**E′**) Results of a non-parametric randomization test to show that (**D′**) ubiquitous and subcellular genes (p-value = 0) and anterior and posterior genes (p-value = 0.0018) have significantly different median 3′UTR lengths (i.e., no or little overlap of densities) and (**E′**) that ubiquitous genes are significantly less conserved in their 3′UTRs than subcellular genes (p-value: 0) and posterior genes show higher conservation than anterior genes (p-value: 0.0032).**DOI:** [http://dx.doi.org/10.7554/eLife.05003.008](10.7554/eLife.05003.008)10.7554/eLife.05003.009Figure 3---figure supplement 1.Ovary gene sets have specific expression patterns during embryogenesis.Linear hierarchy ([@bib62]) plot showing at which embryonic stage and in which tissue the oogenesis gene sets are re-expressed during embryogenesis. Each colour-coded bar represents organ systems of the embryo from its stage-specific anlagen to primordia to final differentiated structures. The width of the bar is proportional to the frequency with which this annotation term was used in the embryo data set; the height corresponds to a z-score of over- (above axis) or under-representation (below axis) of the term in the set of genes defined by ovary annotation. The following oogenesis gene sets are shown: ubiquitous, nuclear, cellular, subcellular, no signal, nurse cells perinuclear, oocyte-enriched, oocyte anterior and oocyte posterior and apical in epithelial cells. Genes expressed ubiquitously in the ovary mostly remained ubiquitous in the embryo and were additionally enriched in meso- and endoderm; genes of the cellular gene set are enriched in ectoderm/epidermis cells of the late embryo; subcellular genes were highly expressed in the ectoderm and nervous system of the embryo. Most 'no signal' genes are also underrepresented in almost all stages and tissues of embryogenesis, apart from the PNS and ectodermal derivatives in the late stages of embryogenesis. Perinuclear enriched genes are highly expressed in meso- and endoderm tissues. Oocyte enriched, oocyte anterior, and oocyte posterior genes are overall very similarly expressed during embryogenesis, being high in the polarized CNS and ectoderm tissues.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.009](10.7554/eLife.05003.009)10.7554/eLife.05003.010Figure 3---figure supplement 2.Gene features of subcellular enriched mRNAs.(**A**) Boxplots showing the median mRNA expression measured by 3Pseq per gene set in early and full ovaries and in 0--2 hr embryos. At the onset of embryogenesis, the cellular mRNAs were almost as low as the 'no signal' class, confirming their predominant expression in somatic cells that at this time-point have undergone apoptosis. Accompanying the boxplot is the matrix of statistical significance tests (Kolmogorov--Smirnov) of the null hypothesis that the distributions of median expression values across the subcellular gene sets are the same. Statistically significant differences (p \< 0.01) are shown in dark grey, while gene sets that did not differ significantly are shown in light grey (p \> 0.01). (**B**--**I**) Boxplots showing the median gene length (**B**), exon length (**C**), intron length (**D**), 5′UTR length (**E**), intron number (**F**), exon number (**G**), intron proportion (**H**), and exon proportion (**I**) for each gene set and the corresponding significance level calculated by the Kolmogorov--Smirnov (KS) test. Statistically significant differences (p \< 0.01) are shown in dark grey, while gene sets that did not differ significantly are shown in light grey (p \> 0.01).**DOI:** [http://dx.doi.org/10.7554/eLife.05003.010](10.7554/eLife.05003.010)10.7554/eLife.05003.011Figure 3---figure supplement 3.Embryo localized mRNAs also have long, conserved 3′UTRs.Distributions of median 3′UTR length (**A**) and conservation of the 3′UTR sequence (**B**, across 24 Drosophila species) for embryo gene sets. Shown are genes that are ubiquitously expressed during embryogenesis, genes whose RNAs were enriched at the apical or basal membrane in blastoderm embryos and RNAs at the posterior pole.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.011](10.7554/eLife.05003.011)10.7554/eLife.05003.012Figure 3---figure supplement 4.Cytoplasmic but not nuclear mRNA localization requires the cytoskeleton.(**A**) Localization of anterior and posterior mRNAs is lost upon microtubule depolymerization by colchicine. Shown are the anterior mRNAs *fs(1)K10* and *milt* (examples for diffuse-anterior and tight-anterior localization) and the and posterior mRNA *vkg* and *zpg* (examples for diffuse-posterior and tight-posterior). The appearance of the ubiquitous mRNA *msl-2* is unchanged in colchicine treated egg-chambers. For details see [Supplementary file 8](#SD8-data){ref-type="supplementary-material"}. (**B**) Summary of the quality of all anterior and posterior mRNA distributions tested in colchicine treated egg-chambers (round aggregates, tiny aggregates, dispersed and diffuse aggregates). Diffuse aggregates were observed for those mRNAs that in wild type egg-chambers showed a diffuse posterior enrichment (e.g., [Figure 1B'](#fig1){ref-type="fig"}: *fs(1)N*). (**C**) mRNA localization in proximity to the nucleus is lost in colchicine treated egg-chambers (*Scp2*), RNAs localized partially nuclear and partially perinuclear loose the cytoplasmic localization (*CG11076*) while strictly nuclear RNAs are unaffected by microtubule depolymerization (*rhi*). (**A**,**C**) FISH experiments showing the RNA in green; DNA (labelled with DAPI) is shown in magenta (**A**) or blue (**C**), the nuclear membrane is stained with WGA dye shown in red (**C**). Scale bar 30 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.012](10.7554/eLife.05003.012)10.7554/eLife.05003.013Figure 3---figure supplement 5.Posterior mRNA localization is impaired in posterior localization pathway mutants.(**A**) Localization of the novel posterior candidate mRNAs *vkg, TwdlG, PI3K21B*, and *zpg* is lost in egg-chambers that prematurely depolymerize the microtubules (flies homozygous for *Spire*^*RP*^), are mutant for the RNA binding protein Staufen (flies homozygous for *Stau*^*D3*^) or mutant for the EJC protein Barentz (flies homozygous for *Btz*^*1*^). The candidate mRNAs are mis-localized in a manner similar to *oskar* mRNA. In *Btz*^*1*^ egg-chambers a weak enrichment of *vkg* mRNA remained that in rare instances is also observed for *oskar* mRNA. (**B**) In egg-chambers either lacking functional Oskar protein or posterior oskar mRNA, the localization of the candidate posterior mRNAs was lost: In Oskar protein mutant egg-chambers (*osk*^*84*^*/Df(3R)*^*pXT103*^), *oskar* mRNA is initially localized at stage 9 but successively detaches from the posterior pole resulting in reduced *oskar* mRNA at the posterior pole from stage 10 onwards. A similar reduction from stage 9 to 10 was seen for *vkg* and *TwdlG* mRNAs, while *PI3K21B* (already in wild type being localized at low levels) and *zpg* mRNA (in wild type localized after stage 9) never showed localization. In egg-chambers that do not express posterior *oskar* mRNA (*oskar 3*′*UTR/+; osk*^*A87*^*/Df(3R)*^*pXT103*^; [@bib36]) none of the candidate posterior mRNAs localized. (Expression of the non-localizing *oskar* 3′UTR is necessary to rescue the early oogenesis arrest.) (**A**--**B**) FISH experiments showing the RNA in green and DNA (labelled with DAPI) in magenta. Scale bars 30 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.013](10.7554/eLife.05003.013)

We next investigated whether there are further global features that could set localized mRNAs apart from ubiquitous ones. Ovarian expressed mRNAs differed in their expression levels over several orders of magnitude. Using our stage specific 3Pseq data, we analysed the expression levels for each gene set. Ubiquitous and subcellular mRNA expression levels were overall comparable however, the posterior class was expressed significantly higher than all other localization classes, including the related anterior mRNAs ([Figure 3C--C\'](#fig3){ref-type="fig"}, [Figure 3---figure supplement 2A](#fig3s2){ref-type="fig"}). Considering how seemingly inefficient posterior transport is ([@bib67]), higher expression levels could be an additional measure to ensure that enough mRNAs will eventually localize. In particular, the late phase accumulation of posterior localized mRNAs in the enlarged oocyte ([@bib23]; [@bib53]) could benefit from high expression levels.

Yet, expression level alone cannot account for subcellular localization. We therefore compared the gene-level variables of each localization class and revealed that subcellular mRNAs had significantly longer 3′UTR sequences and this was more pronounced for the posterior localization class ([Figure 3D,D\'](#fig3){ref-type="fig"}). The posterior gene set further showed longer gene structures, longer 5′UTRs, longer exons and introns, a higher number of exons and introns, and a higher intron proportion compared to ubiquitous and anterior mRNAs ([Figure 3---figure supplement 2B--H](#fig3s2){ref-type="fig"}). Consistent with the observation that localized mRNAs are enriched in non-coding portions, the exon proportion was the highest in the ubiquitous gene set ([Figure 3---figure supplement 2I](#fig3s2){ref-type="fig"}). The high intron proportion of posterior genes is particularly interesting in light of the recent finding that the stable deposition of the exon junction complex, required for posterior *oskar* mRNA localization, is correlated with long intron-containing genes ([@bib2]; [@bib25]). Localized genes not only had longer 3′UTRs, but also showed higher 3′UTR sequence conservation than ubiquitous genes, and again this was significantly more pronounced in the posterior gene set ([Figure 3E,E\'](#fig3){ref-type="fig"}). We also observed longer and more conserved 3′UTRs in the embryo localized mRNAs (apical, posterior) compared to the embryo ubiquitous mRNAs ([Figure 3---figure supplement 3A,B](#fig3s3){ref-type="fig"} based on data from \[[@bib40]\]), indicating that these features are not specific to oocyte-localized mRNAs.

The posterior gene set shows clearly distinct functional and gene architectural features compared to all the other categories. We therefore decided to investigate whether the cytoplasmic localization of the novel candidate mRNAs depends on the known components of RNA localization machinery in the oocyte. First, we probed the dependency of mRNA localization on the microtubule cytoskeleton. Transport of known mRNAs towards the anterior and the posterior pole of the oocyte requires an intact microtubule cytoskeleton (reviewed in [@bib58]). We observed that the localization of all new anterior and posterior candidate mRNAs is lost in colchicine-treated egg-chambers, while ubiquitously distributed mRNAs or RNA foci in the nucleoplasm, that lacks a microtubule cytoskeleton, were unaffected by the colchicine treatment ([Figure 3---figure supplement 4A--C](#fig3s4){ref-type="fig"}, [Supplementary file 8](#SD8-data){ref-type="supplementary-material"}).

However, mRNA localization requires more than an intact microtubule cytoskeleton. We therefore next investigated the localization of candidate posterior mRNAs in mutant egg-chambers that affect the localization of the known posterior mRNA, *oskar*. Posterior transport of *oskar* mRNA requires components of the exon junction complex, the RNA binding protein Staufen and an intact microtubule cytoskeleton ([@bib64]; [@bib57]; [@bib21]; [@bib27], [@bib28]; [@bib45]). The posterior enrichment of the selected candidate mRNAs was severely reduced in egg-chambers mutant for an exon junction complex component (*Btz*^*1*^), that has a disrupted cytoskeleton (*Spire*^*RP*^) or that lack Staufen (*Stau*^*D3*^) protein. The localization of all candidate posterior mRNAs resembled the mis-localized *oskar* mRNA in these mutant conditions ([Figure 3---figure supplement 5A](#fig3s5){ref-type="fig"}).

Oskar protein is a known to be required for the assembly of functional pole plasm and the subsequent localization of mRNAs such as *nanos* ([@bib21]; [@bib22]). Therefore, we next investigated whether the novel candidate mRNAs also require Oskar protein for their posterior localization. We used genetic combinations that result in lack of Oskar protein (*osk*^*84*^*/Df(3R)p*^*XT103*^). In these Oskar protein deficient egg-chambers *oskar* mRNA is initially localized at the posterior pole at stage 9. However, the mRNA becomes successively detached from stage 10 onwards due to the lack of Oskar protein-mediated RNA anchoring ([@bib21]; [@bib65]). The novel candidates initially localized in the absence of Oskar protein at stage 9 but their posterior localization was reduced from stage 10 onwards ([Figure 3---figure supplement 5B](#fig3s5){ref-type="fig"}). Based on these experiments, we propose that the initial posterior localization of the candidate mRNAs, unlike the localization of *nanos* mRNA, is independent from Oskar protein.

Interestingly, if we completely remove posterior *oskar* RNA from the egg-chambers (*osk*^*A87*^*/Df(3R)p*^*XT103*^) ([@bib36]), we do not observe posterior signal for any of the novel candidate mRNAs, both at stage 9 and stage 10 ([Figure 3---figure supplement 5B](#fig3s5){ref-type="fig"}). We propose that the novel candidate mRNAs require *oskar* mRNA to initially reach the posterior pole and Oskar protein to remain stably anchored at the posterior pole beyond stage 9. The notable exception is *zpg* mRNA, that adopts posterior localization only at late stage 9/early stage 10 egg-chambers. Based on our experiments, we cannot determine whether *zpg* mRNA requires *oskar* mRNA or protein for its localization.

mRNAs do not change transcripts but change localization during oogenesis {#s2-3}
------------------------------------------------------------------------

Our findings revealed that co-localized mRNAs share global features and have similar cytoplasmic requirements for their localization. However, as seen with *zpg,* mRNAs within gene sets differ in the precise timing and consequently regulation of their localization. We therefore investigated the time-course of mRNA localizations in detail. In the oocyte, mRNAs can be oocyte-enriched, anterior or posterior localized ([Figure 4A](#fig4){ref-type="fig"}). By comparing exemplary mRNAs across oogenesis time points ([Figure 4A\'](#fig4){ref-type="fig"}), we observed that after being oocyte-enriched mRNAs could enrich at either anterior (*Dok*) or posterior pole (*ZnT35C*), but also de-localize and show ubiquitous distribution (*exu*). Conversely, mRNAs that showed ubiquitous distribution during early oogenesis could adopt posterior localization at later stages (*aret*). These examples show that multiple combinations of mRNA distributions from early to late oogenesis are possible and mRNAs that belong to the same gene set early are not necessarily grouped together at other time points.10.7554/eLife.05003.014Figure 4.mRNA localizations change across time-points.(**A**) Schematic of changing mRNA distributions in germline cells (nurse cells, oocyte) in stage 4--7 and stage 9--10 egg-chambers. (**A′**) Exemplary mRNAs that show diverging combinations of mRNA localizations over the course of oogenesis: After initially being oocyte enriched at stage 2--7, *Dok* mRNA becomes detectable at the anterior pole, *ZnT35C* mRNA at the posterior pole and *exu* mRNA becomes ubiquitously distributed at stage 9/10. *aret* mRNA being ubiquitously distributed at stage 2--7 becomes weakly detectable at the posterior pole. (**B**) Schematic of mRNA distributions in ovary and embryonic cell types. (**B′**) mRNA expressions in ovarian and embryonic cells. All embryo data are from <http://fly-fish.ccbr.utoronto.ca/>. *Sdc* mRNA is localized where microtubules minus ends are enriched ([@bib12]; [@bib16]; [@bib18]) in the syncytial egg-chamber, in epithelial cells of the ovary and of the stage 4--5 embryo. *Bsg25D* mRNA is oocyte enriched, then localizes at the anterior pole in the oocyte but enriches at the posterior pole in the early embryo. Similarly, *ssp2* mRNA enriches in the oocyte during oogenesis and localizes towards the posterior pole in early embryos but during late oogenesis undergoes a ubiquitous phase. *CG14814* mRNA is initially ubiquitous, then shows perinuclear localization and in early embryos is enriched at the posterior pole. (**A′**--**B′**): FISH showing the RNA in green and DNA (labelled with DAPI) in magenta. Scale bar 30 μm. Embryo data are from <http://fly-fish.ccbr.utoronto.ca/> ([@bib40]).**DOI:** [http://dx.doi.org/10.7554/eLife.05003.014](10.7554/eLife.05003.014)

The same dynamics was also apparent when we compared localizations beyond the oocyte ([Figure 4B](#fig4){ref-type="fig"}). Maternal mRNAs that eventually enriched at the posterior pole during early embryogenesis showed any combination of mRNA distributions during oogenesis ([Figure 4B\'](#fig4){ref-type="fig"}). For example, the anterior, ubiquitous and perinuclear mRNAs *Bsg25D, ssp2* and *CG14814* are all eventually enriched at the posterior pole in early embryos ([@bib40]; [fly-fish.ccbr.utoronto.ca](http://fly-fish.ccbr.utoronto.ca)).

The changes in mRNA localization status within the oocyte over time prompted us to ask whether this could be explained by transcriptional regulation during oogenesis. Are we observing different transcript variants that differ in their cytoplasmic distribution? Alternative splicing was previously shown to differentially regulate mRNA localization by producing localized and non-localized isoforms of the same gene ([@bib66]; [@bib29]). We therefore probed our stage-specific transcriptomic data for changes in gene and isoform expression. For the exemplary mRNAs shown in [Figure 4](#fig4){ref-type="fig"}, we could not detect significant changes in the expressed isoform (measured by RNAseq) or the 3′UTR end (measured by 3Pseq; [Figure 5A](#fig5){ref-type="fig"}).10.7554/eLife.05003.015Figure 5.mRNA expression is stable during oogenesis.(**A**) Changing localization of *ZnT35C, exu, aret, Dok, Bsg25D* and *ssp* mRNAs across time-points (see [Figure 4](#fig4){ref-type="fig"}) does not coincide with a change in transcript expression: the expressed 3′UTRs (sampled by 3′prime sequencing, red) and transcript isoforms (sampled by RNAseq, green) do not change from early oogenesis to late oogenesis/early embryogenesis. (**B**) Pair-wise correlation of early/late 3Pseq data revealed that the stage-specific transcriptomes were highly similar (Pearson Correlation: 0.79); only few genes, highlighted in black, were significantly up- or down-regulated (p-value adjusted for multiple testing \<0.1). (**C**) Correlation analysis of expressed transcript isoform (deduced from RNAseq data) revealed that from early to late ovaries almost no transcript-isoforms significantly changed in their expression level. Transcripts with significant changes are shown in black. (**D**) Only ∼300 genes (early-full: 298; late-full: 308; full-embryo: 346) changed their mean-weighted 3′UTR length that is indicative of an alternative polyadenylation. Alternative UTR form usage across oogenesis was found for 1 (early-late oogenesis)/4 (late-full oogenesis) anterior mRNAs (red) and for 4 (early to late oogenesis)/5 (late to full oogenesis) posterior mRNAs (blue).**DOI:** [http://dx.doi.org/10.7554/eLife.05003.015](10.7554/eLife.05003.015)10.7554/eLife.05003.016Figure 5---figure supplement 1.The transcriptome shows little variation over the course of oogenesis.(**A**) Scatterplot showing high correlation (Pearson Correlation 0.71) between RNAseq and 3Pseq sequencing results. (**B**) Stage-specific sequencing reveals that ∼5500 genes (grey) were detected by both mRNA sequencing (RNAseq) and 3′prime end sequencing (3Pseq). Additional 1000--2000 mRNAs were captures with either RNAseq (green) or 3Pseq (red) only, suggesting that at each time point about half of the *D. melanogaster* genome was expressed. (**C**) Venn diagram showing that most genes, 85%, are continuously expressed as they are detectable at each time point of oogenesis (3Pseq: red; RNAseq: green). (**D**) Across oogenesis RNA levels were highly correlated, suggesting minimal changes in the stage-specific transcriptomes (Pair-wise correlation, Pearson Correlation: 0.77; significantly up/down regulated genes shown in black: p-value adjusted for multiple testing \<0.1, see also [Figure 5B](#fig5){ref-type="fig"}). (**E**) GO-term analysis of genes significantly up- (arrow up) or down- (arrow down) regulated during oogenesis/early embryogenesis. Particularly genes encoding components of the extra-embryonic layers (vitelline membrane, ECM, cuticle) changed expression levels. (**F**) *nanos* mRNA significantly changes gene expression from early to full ovaries measured by RNAseq (green) and 3Pseq (red). Below: gene model. (**G**) Boxplot showing that the vast majority of genes expressed only one 3′UTR form during oogenesis, suggesting low prevalence of alternative polyadenylation. (**H**) Correlation of expressed transcripts (measured by RNAseq) revealed that only few genes significantly (shown in black) changed the expressed isoform during oogenesis (see also [Figure 5C](#fig5){ref-type="fig"}). (**I**) Only few subcellular localized mRNAs showed significant changes in transcript expression (see **H**). (**J**) The number of transcripts expressed per gene did not change during oogenesis did not differ between ubiquitous and subcellular gene sets (highlighted: anterior \[red\] and posterior \[blue\] genes).**DOI:** [http://dx.doi.org/10.7554/eLife.05003.016](10.7554/eLife.05003.016)

We next asked whether global transcriptional changes occur that could explain differential mRNA localization during oogenesis. In agreement with results from gene expression analyses of whole ovaries measured by microarray ([@bib15]) and RNAseq ([@bib26]), we find that about half of the *D. melanogaster* genes were expressed at each sampled time point and the vast majority of these expressed transcripts, 85%, were detectable at every time point from early oogenesis until embryogenesis ([Figure 5---figure supplement 1B,C](#fig5s1){ref-type="fig"}). Also the expression levels across time points were highly correlated ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}), suggesting that the transcriptome remained constant throughout oogenesis. Significant up- or down regulation of gene expression levels was only observed for 626 transcripts and among them are only rare examples of germline-specific transcripts (padj \< 0.1, [Figure 5B](#fig5){ref-type="fig"}: black data points, [Supplementary files 2--4](#SD2-data SD3-data SD4-data){ref-type="supplementary-material"}, [Figure 5---figure supplement 1E--F](#fig5s1){ref-type="fig"}). Instead, GO-term analysis associated genes under differential expression with extracellular matrix, vitelline membrane, and cuticle formation, consistent with their expression in the somatic epithelial cells ([Figure 5---figure supplement 1E](#fig5s1){ref-type="fig"}). Across the entire oogenesis, we also could not detect shortening or lengthening of the 3′UTRs, changes in the number of transcript ends and while 55% of genes were expressed in alternative isoforms, the vast majority (\>99%) of genes showed no change in isoform expression ([Figure 5C--D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1G--J](#fig5s1){ref-type="fig"}, [Supplementary files 5--7](#SD5-data SD6-data SD7-data){ref-type="supplementary-material"}). Furthermore, the ubiquitous gene set showed similar transcript diversity as subcellular genes. Therefore, changing expression levels, isoform expression, and alternative polyadenylation cannot explain the changing localization of the majority of mRNAs. The stability of the transcriptome from egg chamber formation until the onset of zygotic transcription also suggests that oogenesis is not dependent on transcriptional changes but rather on post-transcriptional regulation of the expressed transcripts, in particular through mRNA localization.

Global changes of mRNA localization during development {#s2-4}
------------------------------------------------------

A substantial portion of expressed mRNAs is localized during oogenesis. Given that the transcriptome is rather stable yet individual mRNAs show changing localizations across oogenesis, we next analysed mRNA localizations during this period globally. Within one cell, the oocyte, only few mRNAs are localized at all time points, while the majority of localizations is temporary with intermittent ubiquitous phases ([Figure 6A](#fig6){ref-type="fig"}). The oocyte has a highly polarized microtubule cytoskeleton that undergoes dramatic re-polarizations across oogenesis (reviewed in [@bib58]). All mRNA localizations we observed were at sites that are known to enrich for microtubule plus or minus ends. Microtubule orientation is a hallmark of cell polarity. In order to compare localizations across oogenesis stages, we categorized the localized mRNAs as being in proximity to microtubule minus- or plus- ends (*plus and minus category* [Figure 6B](#fig6){ref-type="fig"}, inset). We do not show direct association of all localised mRNAs with microtubules. However, microtubule cytoskeleton is required for RNA localization ([@bib58]) and the oocyte enriched, anterior and posterior localizations categories correspond to where the microtubule minus and plus ends are enriched ([@bib60]; [@bib35]).10.7554/eLife.05003.017Figure 6.mRNA localizations are changing across cell types and within cells over time.(**A**) In the oocyte, most mRNAs of the subcellular category also have phases with ubiquitous mRNA distribution. (**B**) The number of localized mRNAs in the oocyte varies over oogenesis time points. mRNAs are grouped according to their relative localization with respect to the polarised microtubule cytoskeleton ([@bib58]). Red = mRNAs that localize where microtubule minus ends are enriched (minus category), blue = mRNAs in proximity of microtubule plus ends (plus category). (**C**) Time course of clustered single mRNA localizations. Each line represents an mRNA, indicated below are the oogenesis time-points. Localizations to the poles of the oocyte are colour-coded in red (minus category) or blue (plus category); ubiquitous phases of the mRNA are shown in grey. A summary of the trend of mRNA localizations in each cluster and the number of entries is shown to the right. (**D**) Overlap of mRNAs localized in either germline (oocyte, nurse cells), epithelial (follicle cells) and embryonic cell types shown as a Venn-diagram: Only 5 (\<1%) mRNAs localized in all sampled cell types, 89 (14%) mRNAs localized in at least two cell types. The largest group in each cell type was mRNAs localized in proximity to sites known to be enriched for microtubule minus-ends ([@bib12]; [@bib16]; [@bib18]); in the early egg-chamber: oocyte-enriched; in somatic epithelial follicle cells: apical; in embryonic epithelial cells: apical. Only 3 mRNAs (\<1%) showed this localization in all cell types, 29 mRNAs (9%) in two cell types.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.017](10.7554/eLife.05003.017)10.7554/eLife.05003.018Figure 6---figure supplement 1.Changing localization of mRNAs in ovaries and embryos.(**A**) Expanded dendrogram from [Figure 6C](#fig6){ref-type="fig"} including the data for the first two time-points of embryogenesis ([@bib40]). mRNAs at the anterior (minus category) and posterior (plus category) poles further decrease from oogenesis into early embryogenesis; more posterior (plus category) mRNAs remain localized in the embryo than anterior (minus category) mRNAs. A rise in localization of the oocyte-localized mRNAs was only observed at stage 4--5 of embryogenesis; the rise was more pronounced in the minus category (i.e., apical localization in embryo cells). (**B**) Minus and plus categories expanded to the embryo localization data. (**C**) Comparison of the in situ hybridization screens in ovaries (our data) and Drosophila embryos ([@bib40]). In total 1674 mRNAs are subcellularly localized during oogenesis and/or embryogenesis and therefore are 'localization competent' (see also [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). (**D**) Venn diagram of the mRNAs showing nuclear enrichment in either oogenesis or embryogenesis. Only three mRNAs are nuclear at both developmental time-points.**DOI:** [http://dx.doi.org/10.7554/eLife.05003.018](10.7554/eLife.05003.018)

At the different time-points of oogenesis the number of localized mRNAs varied; it was the highest at stage 2--7 and dropped to around 100 mRNAs at stage 8 and increased only slightly again towards stage 10 of oogenesis ([Figure 6B](#fig6){ref-type="fig"}). Also, the number of mRNAs in the minus and plus categories changed yet at different rates: during early oogenesis, the majority of mRNAs are in the minus category but the number of genes in this category rapidly dropped at stage 8 and further decreased throughout oogenesis. In contrast, the mRNAs in the plus category were increasing towards the end of oogenesis ([Figure 6B](#fig6){ref-type="fig"}).

To understand these trends in more detail, we plotted individual mRNAs over the course of oogenesis and clustered them by the localization category. Using this 'localization-dendrogram', we revealed that the changing localization of single mRNAs ([Figure 4](#fig4){ref-type="fig"}) is a global feature of localized mRNAs and occurred at all stages of oogenesis ([Figure 6C](#fig6){ref-type="fig"}). Using the localization dendrogram, we observed several groups: mRNAs that remained in the minus category at all time points, mRNAs that switched from minus category to ubiquitous distribution (this was by far the biggest category), mRNAs that switch from minus to plus category (with and without intermittent ubiquitous distribution) and ubiquitous mRNAs that become localized and affiliated with the plus category. It is noteworthy that such de novo localization of an initially ubiquitous transcript was not observed for the minus category. The dendrogram also revealed that such changes in localization occurred at all time points of oogenesis: mRNAs could switch from minus category to ubiquitous distribution at stage 8, 9 or 10 or enrich in the plus category, that is, adopt posterior localization at stage 9 or 10 of oogenesis. These localization time-courses recapitulate the localization pattern of the well-characterized, singular mRNAs such as *oskar*, *gurken*, *nanos*, and *bicoid*; however, our data show that each of them occurs for multiple co-regulated mRNAs.

It has been shown that mRNA localization to the oocyte portion of the syncytial egg-chamber, to the apical side of somatic epithelial cells of the ovary and of embryonic epithelial cells in the embryo (stage 4--5) is functionally equivalent ([@bib7]; [@bib34]). Indeed, we observed mRNAs that were oocyte enriched and apical in epithelial cells ([Figure 4B\'](#fig4){ref-type="fig"} *Sdc*). How general is this phenomenon? Does the majority of mRNAs localize to equivalent sites in different cell types or is it a property of singular mRNAs? To address these questions, we use again the microtubule polarity as a universal proxy of cell polarity that enables comparison of equivalent localization sites across tissues. This allows us to extend the minus and plus categories in ovaries to include data from embryos ([@bib40]). Minus category includes additionally apical sets from embryo and plus category includes pole plasm and basal embryonic enrichment categories ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). We do not include pole cell annotations in the plus category since this is not a subcellular localization but rather a cell-specific expression pattern. The posterior pole plasm and anterior embryo categories reflect the polarity of embryonic body axis and do not imply any microtubule-related localization mechanism. It is for instance known that some RNAs become restricted to the posterior pole by selective degradation protection mechanism (reviewed in [@bib42]). This grouping enables us to compare localization of mRNAs between life cycle stages (ovaries and embryos) and cell types (germline and epithelial cells).

To address whether oogenesis localized transcripts remain localized into early embryogenesis, we extended the localization dendrogram to stage 1--3 (maternally loaded transcripts) and stage 4--5 (after the onset of zygotic transcription) of embryogenesis ([Figure 6---figure supplement 1A,B](#fig6s1){ref-type="fig"}). This revealed that only very few of the minus and plus category mRNAs remained localized in embryogenesis: only three of the minus category mRNAs and a few more in the plus category. The plus category increased slightly at stage 1--3 of embryogenesis as a few ubiquitous oogenesis transcripts became localized. A rise of mRNAs in the minus category was only detectable at stage 4--5 of embryogenesis (apical localization) when the initiation of zygotic transcription occurs. We conclude that mRNAs are differentially localized in different developmental contexts.

Since many oocyte localized genes are also expressed in the somatic epithelium of the ovary and again during embryogenesis, we next wondered whether localization is preserved in different cell types. We took advantage of the wealth of FISH data now available for *Drosophila* and combined our data for the somatic epithelial cells and the germline (nurse cells, oocyte) cells of the ovary with the FISH screen performed on embryonic cells ([@bib40]). These screens in combination covered 9114 genes of which 1674 mRNAs showed subcellular localization at least at one time point either during oogenesis or embryogenesis and thus are 'localization competent' ([Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}). Filtering of the data sets for mRNAs that were probed by FISH in all three cell types resulted in 720 mRNAs of which only five mRNAs were localized in all three, and 89 mRNAs were localized in two cell types ([Figure 6D](#fig6){ref-type="fig"}). Strikingly, the data also show that with respect to microtubule polarity, only three mRNAs were in each cell type localized to the side where also microtubule minus ends are enriched (*Dok, Sdc, CG12006;* [Figure 6D](#fig6){ref-type="fig"}). Other types of localization, for example, nuclear RNA enrichment, had similarly minimal overlap across cell types ([Figure 6---figure supplement 1D](#fig6s1){ref-type="fig"}). The relative lack of mRNA localization to equivalent subcellular destinations indicates that while many mRNAs are localization competent, their localization appears to be cell type specific and developmentally regulated.

Discussion {#s3}
==========

We generated a comprehensive resource, the Dresden Ovary Table (DOT, <http://tomancak-srv1.mpi-cbg.de/DOT/main.html>) that includes stage-specific transcriptomic and image-based RNA expression and subcellular localization data for the entire oogenesis from cystoblast division to the beginning of embryogenesis. Our resource consists of 52,000 carefully selected, annotated, stage-specific images of ovarian gene expression, and localization patterns that can be searched online or downloaded for in-depth computational analysis. The curated images are linked to 32,000 raw 3D image stacks available for interactive browsing that will facilitate further discovery. The ovary data set is integrated with similar data on gene expression and RNA localization patterns in *Drosophila* embryos ([@bib62]) enabling comparisons between tissues on a gene-by-gene basis. All visual expression patterns are described with controlled vocabularies facilitating searches and grouping of co-regulated genes. Together, this resource represents one of the most comprehensive databases of spatio-temporal gene expression patterns for two intensively studied developmental systems. The vast majority of the patterns shown in DOT are novel, often providing the very first data for computationally predicted genes. This makes the resource an excellent starting point for in-depth mechanistic studies and for enrichment analysis of gene sets generated in other genomics studies.

The global analysis of the annotation data allowed us to define gene sets of co-localized mRNAs and show that localized, particularly posterior mRNAs, have a more complex gene structure, longer and higher conserved non-coding features and higher expression levels than ubiquitous mRNAs. These properties of localised mRNAs are significant for both the oogenesis and embryogenesis data sets. Although they are not by themselves predictive of the localization status of individual mRNAs, it will be interesting to examine these properties in other cellular and developmental contexts. Our analysis, for example, predicts that the neuronal transcripts that must reach the distant synaptic compartments, would encode long, highly expressed transcripts analogous to the posterior localization gene set in the oocyte.

Similarly to embryonic cells, ovarian cells also show prevalent subcellular mRNA localizations. In contrast to the embryo system ([@bib40]), ovarian cells displayed more homogenous subcellular enrichments. With few exceptions, the candidate mRNAs localized at sites known to be enriched for either microtubule minus or plus ends. Curiously, we observed that the ovarian localized mRNAs themselves are strongly enriched for genes with cytoskeletal functions, as were localized mRNAs in the embryo ([@bib40]). This is particularly interesting in light of a recent model suggesting a self-organizing principle for the polarized cytoskeleton in mouse neurites through localized mRNAs and localized translation ([@bib49]). A local source of cytoskeletal proteins, for example, in the early oocyte could be beneficial to allow the rapid re-organization and growth of the cytoskeleton at the transition from early to mid-oogenesis. Next to cytoskeletal regulating factors, anterior mRNAs that localize in proximity to the meiotic oocyte nucleus were enriched for terms assigning a cell cycle regulating function. It will be interesting to investigate whether anterior mRNA localization affects meiosis, a process shown to be regulated through translational control ([@bib59]; [@bib3]; [@bib17]; [@bib38]). Curiously at stage 9 and 10, we also identified mRNAs enriched in the nuclei of the oocyte. These mRNAs could either be nurse cell transcripts imported into the meiotic oocyte nucleus or else the controversial instances of transcription from the meiotic nucleus ([@bib50]; [@bib9]).

Cross-tissue and time-course analyses revealed the changing mRNA localization profile during development and that the well-described, canonical examples of mRNA localization in the ovary ([@bib4]; [@bib57]; [@bib21]; [@bib46]) represent classes of co-regulated mRNAs. Considering that the transcriptome appears stable, we find it surprising that the same mRNA isoforms and thus the same primary sequences show such differential localizations during oogenesis. Such pervasive changes in localization status of mRNAs contradict the model that mRNAs localize through sequence encoded mRNA zipcodes (reviewed in [@bib44]) and that the general localization machinery is active in all cell types analysed ([@bib7]; [@bib34]). It will therefore be interesting to investigate whether specificity of mRNA localization is based on selective, cell-type-specific mRNA regulation machinery or a zipcode signal that is under specific temporal control. mRNAs can, for example, harbour two consecutively acting localization signals that direct mRNAs sequentially to opposing microtubule ends ([@bib25]; [@bib34]). However, how one signal is de-activated and the other activated is yet unknown. Alternatively, only few mRNAs could have a zipcode for their localization and the vast majority would be co-transported with these regulated mRNAs in large transport granules. Finally, it is also conceivable that subcellular mRNAs could be locally trapped by unidentified physical properties of subcellular cytoplasmic domains or that similarly to the early embryo, some localization patterns result from protection from general cytoplasmic degradation (reviewed in [@bib42]). All these mechanisms could be active consecutively or in combination during development, which could result in the observed diversity in mRNA localization.

Regardless of the specific mechanisms of mRNA transport, our genome-wide analysis shows that mRNA localization is a phenomenon contingent on the cellular context and is most likely highly regulated during development. It also highlights that oocytes do not rely on transcriptional but on post-transcriptional mechanisms to regulate gene expression, in particular (but likely not limited to) mRNA localization. Our resource enables the transition from deep mechanistic dissection of singular mRNA localization events towards systemic examination of how mRNAs transcribed in the nucleus distribute in cells and how this affects cellular architecture and cell behaviour in development.

Materials and methods {#s4}
=====================

Mass isolation of *Drosophila* egg-chambers {#s4-1}
-------------------------------------------

Flies were grown under standard laboratory conditions, fed for 2 days with fresh yeast at 21 and 25°C. For isolation of egg-chambers, we developed a mass isolation protocol (see below) that allows us to enrich separated egg-chambers of all stages.

RNA isolation, sequencing, and analysis {#s4-2}
---------------------------------------

We isolated total mRNA using TRIreagent (Sigma Aldrich, Germany) from stage 1 to 7 egg-chambers, including the germline stem cells, from stage 8 to 10 egg-chambers and from total ovaries containing mainly stage 11 and older egg-chambers. Additionally, RNA from 0 to 2 hr embryos was isolated. We used two complementary mRNA sequencing approaches; standard whole mRNA sequencing (RNAseq) and a sequencing method, 3Pseq, that captures specifically the sequence adjacent to the poly(A) tail. Our 3Pseq protocol is similar to the SAPAS method described previously ([@bib24]). In contrast to SAPAS, total mRNA was fragmented chemically, resulting in 200 nucleotide long molecules. cDNA was generated and amplified using a polyT primer terminating with a dinucleotide made of non-T followed by a random base and a 5′ template switch primer; both primers containing Illumina adaptors. This allowed us to capture each expressed polyadenylated mRNA once and thereby precisely quantify expression level (Vineeth Surendranath and Andreas Dahl, personal communication). Of the ∼50 million (3Pseq) and 100 million (RNAseq) Illumina reads, we mapped 70% (3Pseq) and 90% (RNAseq) to the *D. melanogaster* release 5.52 genome with Bowtie. Quantification was done using HTSeq ([@bib1]). Normalization and differential expression was done using DESeq ([@bib1]). Noise thresholds of 70 and 50 counts, for RNAseq and 3Pseq respectively, were derived from observing the distributions of normalized counts. 3′UTR forms were assigned by overlaying annotated Flybase UTR forms with 3Pseq reads lying within 200 nucleotides of the annotated 3′UTR end. Alternate Polyadenylation events were called by calculating the mean-weighted UTR length ([@bib63]), a difference of 200 nucleotides in the mean-weighted lengths corresponding to two biological stages resulted in the gene being considered as undergoing Alternate Polyadenylation.

96-well fluorescent in situ hybridization {#s4-3}
-----------------------------------------

We used an established protocol for in situ hybridization in 96-well plates ([@bib62]) with minor adaptations (see below): we added an over-night wash step after hybridization, incubate the anti-DIG antibody over night and used fluorescent tyramides for probe detection. Each experiment was evaluated and imaged using a wide-field microscope (Zeiss Axioplan Imaging, Zeiss, Germany) equipped with an optical sectioning device (DSD1, Andor Technology, UK) to generate confocal-like z-stacks.

Annotation and database {#s4-4}
-----------------------

We developed a controlled vocabulary to describe the cell types and relevant subcellular structures for oogenesis for germline and somatic cells (<http://tomancak-srv1.mpi-cbg.de/cgi-bin-public/ovary_annotation_hierarchy.pl>). Experiments showing no detectable FISH signal were classified as 'no signal at all stages', while experiments resulting in a homogeneous signal throughout oogenesis were classified as 'ubiquitous signal at all stages'. Gene expression patterns were imaged up to stage 10B of oogenesis after which cuticle deposition prevents probe penetration. Each pattern that did not fall in the above-mentioned classes was imaged at all stages of oogenesis in several individual egg-chambers per time point. We collected 3D images and used custom scripts in FIJI ([@bib51]) to manually select and orient representative 2D images that were uploaded to the Dresden Ovarian-expression Table (DOT) (<http://tomancak-srv1.mpi-cbg.de/DOT/main>). The 2D images remain linked to the original image stacks and all the raw stacks that were used to create an exemplary 2D image are available for interactive inspection using a simple image browsing cgi script. Thus, the record of each in situ experiment for a given gene consists of a set of 2D images assigned to a specific oogenesis stage and described using annotation terms selected from the controlled vocabulary. For definition of broad classifications, subclass grouping and embryo annotation class definition, see [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}.

Binary matrix {#s4-5}
-------------

The binary matrix summarizes the data of our screen in tabular form, which facilitates access to the multidimensional image annotation data and integrates them with the RNAseq and 3Pseq data. The binary matrix is a freeze from September 2013, based on which our analyses were done. The binary matrix is provided as a flat file for independent bioinformatics investigation of the data set (<http://tomancak-srv1.mpi-cbg.de/cgi-bin-public/dump_binary_matrix_ovary.pl?db=insitu_ovaries>).

The matrix contains the following information for each annotated gene: the FlyBase ID; the expression levels as raw as well as normalized counts from RNAseq and 3Pseq experiments for early-, late- and full ovaries and 0--2 hr embryos; the pair-wise comparison of expression over the time course analysed, raw and normalized; the mean-weighted length indicating alternative 3′UTR expression.

The binary matrix additionally contains the annotation of FISH expression patterns. The expression terms are from the controlled vocabulary (CV). If the CV term is true its value is equal to one, otherwise it is zero. If a gene is annotated twice during the screen, the CV values are summed up and thus result in values \>1.

We also provide information which clone was used to prepare the FISH probe; the classification into broad annotation classes ('no signal'; 'ubiquitous'; 'specific', see 'Results'. All reliable genes in these categories were used for the analysis and the table in [Figure 1A](#fig1){ref-type="fig"}); classification of specific expression patterns into subclasses ('cellular', 'subcellular', 'nuclear'); reliability status: 'reliable' and 'non-reliable' (genes probed with more than one RNA probe that resulted in conflicting annotations \[n = 247\], were labelled as 'not reliable'. 185 'unreliable' cases resulted from a 'no signal' vs 'ubiquitous' or 'no signal' vs 'specific' annotations, here we assume one of the probes to be non-functional. 57 'unreliable' annotations were due to different probes giving a 'ubiquitous' and 'specific' signal, respectively. One possibility is that probes were specific to different isoforms of the gene); pn-status: comparison of sequencing and FISH results (TN = true negative: genes expressed below cut-off in either RNAseq or 3Pseq and giving a 'no signal' in FISH experiments. FN = false negatives: genes expressed below cut-off in either RNAseq or 3Pseq and giving a 'ubiquitous' or 'specific' in FISH signal. TP = true positives: genes expressed above cut-off in either RNAseq or 3Pseq and giving a 'ubiquitous' or 'specific' in FISH signal. FP = false positives: genes expressed above cut-off in either RNAseq or 3Pseq and resulting in a 'no signal' FISH annotation (see [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"})).

GO-term analysis {#s4-6}
----------------

For GO-term enrichment of gene sets we used the DAVID web server ([@bib30]). Terms or features enriched at a false discovery rate (FDR) of ≤10% and/or a Benjamini p-value of \<0.1 were considered significant. Two stringencies were applied: the standard FDR cut-off (≤10%) or the more stringent 'Benjamini' p-value (≤0.1).

Colchicine treatment and mutant analysis {#s4-7}
----------------------------------------

Flies were fed for 15 hr at 25**°**C with fresh yeast paste supplemented with 50 μg/ml colchicine ([@bib13]). The effect of colchicine on individual egg-chambers was determined by scoring the detachment of the oocyte nucleus from the anterior cortex and its migration towards the centre of the oocyte. To test posterior localization in mutants that affect *oskar* mRNA localization we used ovaries from homozygous *Spire*^*RP*^ ([@bib43]), *Stau*^*D3*^ ([@bib56]), and *Btz*^*1*^ ([@bib64]) flies. Further, we analysed egg-chambers from *osk84/*Df(3R)p^XT103^ flies lacking functional Oskar protein ([@bib41]) and from *oskar*3′UTR/+;*oskA87*/Df(3R)p^XT103^ flies that entirely lack endogenous *oskar* mRNA but develop past the early oogenesis arrest characteristic for *oskar* RNA null flies due to a transgenic source of oskar 3′UTR ([@bib36]) that is incapable posterior localization.

Gene feature variable {#s4-8}
---------------------

For analysis of the annotated gene features, we used the flybase gff data (*D. melanogaster* release 5.52).

3′UTR length and conservation {#s4-9}
-----------------------------

For each gene, we defined the most used UTR form as the form that was most highly expressed (relative to any other forms expressed from the same gene) and which had UTR ends that overlapped by ± 200 bp with a FlyBase annotated UTR end. From this data, we extracted unique 3′UTR lengths for each gene. Sequence conservation of 3′UTRs was measured as median phyloP scores ([@bib48]) across all bases in the most used UTR form for 3′UTR sequence alignments across 24 *Drosophila* species (using the *D. melanogaster* UTR co-ordinates). PhyloP scores were calculated using the R package *Rphast* ([@bib31]). Median UTR lengths and conservation scores were bootstrapped by re-sampling genes with replacement from selected annotation sets 100,000 times and calculating median values for each re-sample. p-values were calculated as the number of re-samples in which the annotation group with a lower median value was greater than or equal to the re-sampled median of the annotation group to which it was being compared, divided by 100,000.

Protein interactions {#s4-10}
--------------------

A manually curated *D. melanogaster* protein--protein interaction network was downloaded from the mentha interactome database ([@bib11]). To test whether genes belonging to certain annotation groups participated in more protein--protein interactions within the annotation group than expected by chance, we adopted the following randomization-based approach. A random sample, the size of the number of genes in an annotation group that participate in at least one interaction in the total protein interactome, was taken from the total set of genes belonging to the protein interactome, and the number of protein interactions within this random sample was scored, minus loops. This was repeated 100,000 times to generate a distribution of the number of interactions obtained by randomly sampling the number of genes belonging to the annotation group from the total interactome. The p-value was calculated as the number of randomly sampled networks that had as many or more interactions as the real annotation group divided by 100,000.

Protocol: mass-isolation of egg-chambers {#s4-11}
----------------------------------------

Flies were fed with fresh yeast and kept for 1--2 days at 25°C.Mixed sex flies were narcotized with CO~2~ for a maximum of 5 min before proceeding to step 3.Narcotized flies were immediately immersed in 4% Formaldehyde in PBS (for FISH experiments) or in PBS supplemented with 0.1% Tween-10 (for ovarian extract or total RNA isolation).Flies were rapidly processed twice through a grinding mill adaptor at a fine setting (grade step '3') on a standard food processor (Kitchen Aid).The ground flies were size-separated using 850, 450, and 212 μm sieves successively, resulting in a flow-through highly enriched for separated egg-chambers of all stages.Collection of mass-isolated material:a. For FISH experiments, the co-isolation of testis and gut materials did not disturb the subsequent analysis and the material was allowed to settle by gravity and to be fixed for additional 15 min in 4% Formaldehyde, resulting in an overall fixation time of 20 min. The supernatant was then removed, the material washed twice in 1×PBS and then transferred stepwise into 100% methanol for storage at −20°C.b. For isolation of total RNA, we manually selected egg-chambers at early stages (germarium to stage 7, previtellogenesis), late stages (stage 9--10, postvitellogenesis), and full ovaries highly enriched for stage 11+ egg-chambers using a stereomicroscope. For each stage we collected at least 10 μl of total material that was frozen immediately.

Protocol: 96-well plate fluorescent in situ hybridization (FISH) {#s4-12}
----------------------------------------------------------------

Mass isolated egg-chambers were transferred stepwise (MeOH/PBT 3:1; MeOH/PBS 1:1; MeOH/PBS 1:3) into PBT0.1% (each wash few minutes).Egg-chambers were then washed 6× in PBT0.1%, 5 min each.Egg-chambers were briefly washed in PBT0.1%/Hyb 1:1.Pre-hybridization of egg-chambers was done in 200 μl hybridization buffer at 55°C for 1 hr.Egg-chambers were then added to a 96-well plate and hybridized over-night at 55°C in 200 μl hybridization buffer with Dextran Sulfate supplemented with 2 μl of probe.100 μl of warm Wash Buffer was added to each well and immediately removed together with probe-solution.Egg-chambers were rinsed once with 150 μl of Wash Buffer and then washed four times for one hour at 55°C in Wash Buffer.Egg-chambers were then washed five times for 1 hr at 55°C in 150 μl PBT0.1%, the last wash was done over-night at 55°C.Egg-chambers were washed twice for 1 hr at room temperature in 150 μl PBT0.1%.The primary antibody (Anti-Digoxigenin-POD Fab Fragments \[Roche, Germany\]) was diluted 1:200 in PBT0.1% and egg-chambers were incubated in 200 μl antibody solution overnight.Egg-chambers were rinsed with 150 μl of PBT0.1% and then washed ten times for 30 min at RT in 150 μl of PBT0.1%.For detection egg-chambers were incubated with Cy3-Tyramides (Perkin--Elmer, Boston Mass.) 1:70 diluted in amplification buffer for 30 min.Egg-chambers were then washed ten times for 30 min at room temperature in 150 μl of PBT0.1%. DAPI, diluted 1:1000, was included in one wash step.All PBT0.1% was removed and ∼50 μl mounting medium was added.
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###### 

Gene set definitions. Definition of Gene Sets used in this analysis from the ovary and the embryo ([@bib40]) FISH annotation matrices.

**DOI:** [http://dx.doi.org/10.7554/eLife.05003.019](10.7554/eLife.05003.019)
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###### 

Differentially expressed genes (early/late). Genes showing significant differential expression (padj \<0.1) from early to late ovaries. Upregulated genes show log2FolgChange \>0, downregulated genes show log2FolgChange ≤0.

**DOI:** [http://dx.doi.org/10.7554/eLife.05003.020](10.7554/eLife.05003.020)
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###### 

Differentially expressed genes (late/full). Genes showing significant differential expression (padj \<0.1) from late to full ovaries. Upregulated genes show log2FolgChange \>0, downregulated genes show log2FolgChange ≤0.

**DOI:** [http://dx.doi.org/10.7554/eLife.05003.021](10.7554/eLife.05003.021)

10.7554/eLife.05003.022

###### 

Differentially expressed genes (full/0--2h embryos). Genes showing significant differential expression (padj \<0.1) from full ovaries to 0--2 hr embryos. Upregulated genes show log2FolgChange \>0, downregulated genes show log2FolgChange ≤0.

**DOI:** [http://dx.doi.org/10.7554/eLife.05003.022](10.7554/eLife.05003.022)
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###### 

Differential isoform expression (early/late). Transcripts that are differentially expressed from early to late ovaries.

**DOI:** [http://dx.doi.org/10.7554/eLife.05003.023](10.7554/eLife.05003.023)
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###### 

Differential isoform expression (late/full). Transcripts that are differentially expressed from late to full ovaries.

**DOI:** [http://dx.doi.org/10.7554/eLife.05003.024](10.7554/eLife.05003.024)
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###### 

Changes in 3′UTR length. Shown are the mean-weighted changes in 3′UTR length across oogenesis. Values \>0 indicate 3′UTR lengthening, Values \<0 indicate 3′UTR shortening. Only changes affecting \>200 nt are shown.

**DOI:** [http://dx.doi.org/10.7554/eLife.05003.025](10.7554/eLife.05003.025)

10.7554/eLife.05003.026

###### 

Effect of colchicine on oocyte mRNAs. Summary of experiments on colchicine treated egg-chambers; Shown are gene/clone name, localization in wild-type egg-chambers and mRNA appearance upon microtubule depolymerization. Data is available publicly at the DOT, the Dresden Ovary Table (<http://tomancak-srv1.mpi-cbg.de/DOT/main.html>).

**DOI:** [http://dx.doi.org/10.7554/eLife.05003.026](10.7554/eLife.05003.026)

Major datasets {#s6-1}
--------------

The following dataset was generated:

Surendranath V, 2014,Ovary RNAseq and 3Pseq,<http://www.ncbi.nlm.nih.gov/sra/?term=SRP045258>,Also publicly availalble at the DOT, the Dresden Ovary Table <http://tomancak-srv1.mpi-cbg.de/DOT/main.html>.

The following previously published dataset was used:

Eric Lecuyer, *et al*, 2007,Data from: Global analysis of mRNA localization reveals a prominent role in organizing cellular architecture and function,<http://fly-fish.ccbr.utoronto.ca/>,Publicly available at Fly-FISH (<http://fly-fish.ccbr.utoronto.ca/>).
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United States

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

\[Editors' note: this article was originally rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for choosing to send your work entitled "Systematic imaging reveals features and changing localization of mRNAs in *Drosophila* development" for consideration at *eLife*. Your full submission has been evaluated by K VijayRaghavan (Senior editor), Karsten Weis (Reviewing editor), and 2 peer reviewers, and the decision was reached after discussions between the reviewers. Based on our discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The two reviewers agreed that your manuscript provides a very valuable resource for the *Drosophila* community, but felt that your work does not provide sufficient new insight into the biology of RNA localization to warrant publication in *eLife*.

Reviewer \#1:

This report constitutes a valuable resource to *Drosophila* researchers studying oogenesis. The authors provide a description of 1541 FISH stained and imaged mRNAs. This and the bioinformatics analysis was a great endeavor and given their imaging expertise, the Tomancak lab is perfectly suited to tackle this project. However, it is not clear whether the authors provided any new insights into the biology of the mRNA localization. Additionally, in some places the authors oversimplify or over interpret the data (see below). Thus, the value of this manuscript beyond its value as a resource is not tangible. After correction of some of the misstated and misleading interpretations, this article could be suited as a "Resource" rather than the "Article" format. Irrespective where this will be published, the following points need to be addressed: 1) What criteria did the authors use to determine the minus and/or plus end microtubule localization? For example, in the subsection headed "Changing mRNA localization during development", the authors state that 591 mRNAs co-localized with the microtubules minus ends during oogenesis. In the same subsection, they mention that "minus-end accumulation only re-emerged after initiation of transcription...". How did the authors test this localization with the microtubules? The authors should clearly write whether this type of co-localization was assumed for the mRNAs tested based on previous reports or provide data showing this finding. Would it not be better and less confusing to call the localization as "anterior" or "posterior"? It would tell the same story without implying additional mechanisms of localization, which were not tested at all.

2\) [Figure 2--figure supplement 1D](#fig2s1){ref-type="fig"}: the authors conclude that the "minus-end accumulation only re-emerged after initiation of zygotic transcription of the embryo, pointing to a potential link between transcription and minus-end localization of mRNAs". This Figure is misinterpreted as the authors neglect the fact that approximately 60% of the maternally-deposited genome is degraded in the embryo while the germ plasm enriched mRNAs are protected from degradation and remain enriched at the posterior. Thus, in this case degradation will affect the statistics in [Figure 2--figure supplement 1D](#fig2s1){ref-type="fig"} and the conclusion that there is a link between transcription and minus-end localization will not be valid. For example, the localization of Hsp83 mRNA at the posterior pole becomes apparent only after the activation of zygotic genome due to the degradation of un-localized Hsp83 elsewhere in the embryo. Did the authors find Hsp83 as "minus-end" localized in the stage 3--5 embryos? There are many mRNAs that localize to the posterior in a manner like Hsp83 and thus for them too this link between the minus end localization and transcription would be invalid. The authors should correct this error. Since the authors cannot account for the changes in mRNA levels due to mRNA degradation in the embryo this Figure is inherently difficult to interpret and should perhaps be removed from the manuscript.

3\) In the subsection "Posterior localizations depend on oskar mRNA", the authors identified novel mRNAs enriched at the posterior, which in the absence of osk protein are no longer localized at the posterior pole. However, instead of interpreting this finding as an indication that Oskar protein and other germ plasm components are required for the posterior localization of these RNAs, the authors interpret this finding that these novel mRNAs hitchhiked with osk mRNA to the posterior or that oskar mRNA could recruit and stabilize minus ends at the posterior thereby enabling localization of these novel mRNAs. It would have been very exciting if the authors had identified another RNA besides osk itself that could hitchhike with osk or identified a new posteriorly localized RNA that directly, and independently of Oskar protein, requires microtubules for its localization. However, apparently none of their RNAs fit this interpretation, as judged by [Figure 3](#fig3){ref-type="fig"}, where the authors show that localization of all RNAs tested is affected in *osk84/Df*, where, as the authors also show, osk RNA is properly localized. More stringent experiments would have been to determine this question in an *osk166* allele, a missense mutation (rather than the 84 nonsense allele) that affects germ plasm assembly, or other mutations downstream of Oskar that act in the germ plasm assembly pathway (Vasa, Tudor). The most definitive experiment would have been to ask whether these posteriorly localized RNAs localize to the anterior pole in oocytes and embryos expressing osk-bcd3\'UTR, since in this case osk RNA localization is clearly separated from its function in germ plasm assembly.

A more likely interpretation of their result is that Oskar and the assembled germ plasm entraps the other mRNAs enriched at the posterior, as proposed previously for the posteriorly localized RNA nanos (Curr Biol. 2003 July 15;13(14):1159-68). Furthermore, there is to my knowledge no published report that suggests that Oskar has a direct an effect on microtubule polarization. Thus the fact that localization of all RNAs is affected in the oskar RNA and protein null mutants, where microtubule polarity is normal, strongly suggests that these RNAs are not directly localized by microtubule mediated transport. Failure to localize after colcemide treatment is likely a function of loss of oskar localization. It is thus misleading by the authors to interpret the defect in RNA localization after colcemide treatment as evidence for a direct role of microtubules in localization of these RNAs. The authors need to correct this misinterpretation of the data. Additional experiments such as careful analysis of the timing of RNA localization and disruption of the microtubule and actin cytoskeleton at different time points during oogenesis (see Curr Biol. 2003 July 15;13(14):1159-68) would be required to make any conclusions about the mechanisms of localization employed by the described RNAs. As these experiments are likely beyond the scope of the present analysis, the authors should avoid misleading readers.

Minor comments:

In the subsection "Widespread mRNA localization in ovaries", the authors cite the work by Saunders and Cohen to say that the oocyte nucleus is transcriptionally active. Unfortunately, these results were shown to be incorrect by Schupbach and colleagues in Dev Biol. 2000 May 15;221(2):435-46. In this manuscript Schupbach et al. show that the construct used by Saunders and Cohen included 5\'UTR sequences, which are required for localization of grk RNA to the nucleus (see also: Development. 2005 May;132(10):2345-53). To my knowledge there is not a single example that suggests that the oocyte nucleus is transcriptionally active at this stage.

Reviewer \#2:

This manuscript presents a large scale in situ hybridization analysis of transcripts expressed during *Drosophila* oogenesis. The data are of high quality and provide a valuable complement to a previous study of mRNA localization patterns in the early *Drosophila* embryo. However, the analysis is almost entirely descriptive, the results are often not particularly informative, and conclusions are largely speculative.

In particular, it isn\'t clear why the authors find it so surprising that RNAs change localization status in different cell types and at different times. If the goal of mRNA localization is to localize proteins (or restrict their domains), it stands to reason that local requirements for the encoded proteins may be more relevant in certain cell types (e.g. oocyte vs epithelial cells) and at certain developmental times.

In addition, I\'m not convinced that what the authors consider to be changes from microtubule minus-end to plus end localization or de novo plus end localization isn\'t simply a result of transcripts becoming anchored to the posterior cortex, such that they remain there despite changes in microtubule organization. Alternatively, what appears as de novo plus-end localization may actually be due to association of those transcripts with the nascent polar granules organized by Oskar protein, rather a specificity for microtubule plus ends. And the further increase in plus-end localization during embryogenesis does not result from a favoring of plus-end accumulation over minus-end accumulation in the embryo, but rather from the well-documented protection from degradation afforded by the germ plasm.

Finally, the authors state that the novel posterior mRNAs require the same proteins for their localization as oskar mRNA. However, their localization also requires Oskar protein so it is not possible to distinguish whether they themselves require the EJC, Staufen, etc or whether this requirement is secondary to the requirement for these proteins in localization and translation of oskar mRNA. Similarly, while the authors conclude that the posteriorly localized RNAs seem to require oskar mRNA itself, it isn\'t clear that the problem is the lack of oskar RNA or the lack of Oskar protein.

10.7554/eLife.05003.028

Author response

We present a genome-wide analysis of mRNA expression and localization for the entire process of oogenesis in fruit flies that in its content (imaging and transcriptomics) and depth surpasses any similar dataset in any developmental system. Our study is also the very first *comparative analysis of the "localization landscape"* between cell types and within one cell over time. mRNAs use localization elements for intracellular transport that are, analogous to protein domains, a static feature of the transcript. It has been shown that the cellular machinery, which recognizes these localization elements is universally active: expression of an oocyte-specific localization element in epithelial cells of the embryo will lead to equivalent localization (and vice versa). It is therefore highly interesting that:

1\) The same mRNAs can adopt dramatically different subcellular localizations or become unlocalized in different cell types and

2\) That mRNAs within one cell change their subcellular destination over time.

In comparison, a protein that harbors, for example a transmembrane domain, will remain localized to membranes in different cell types. By showing that the *transcriptome does not differ*, we rule out that changing localizations are due to changes in primary sequence of the transcript. This points to as yet un-discovered levels of regulation of mRNA distribution in cells. Importantly, such *conclusion* can *only be made based on genome wide analysis of large-scale resources* such as the ones that we present in this manuscript.

Resources are important and provide unique insights into biological problems in that they enable to generalize the properties of singular, in depth studied mechanistic phenomena. Only the data we collected enabled us to analyze genome encode features that are associated with different classes of RNA localization. We have made several striking observations, for example that RNAs that have to travel the furthest across the large germ-line cell are expressed at significantly higher expression levels. Some of the observations that we made based on the genome wide data may seemingly only confirm prior assumptions about the nature of RNA regulation (such as the length and conservation of UTRs in localized transcript). However, only our data allow us to conclude in a statistically rigorous manner that these assumptions are indeed valid. To finally be able to state using a scientific method that the signals for RNA localization (whatever they may be) are most likely encoded by the genome in the 3'UTRs?

We very strongly disagree with the argument that our resource is only useful to the narrow *Drosophila* research community. In mammalian and *Xenopus* neuronal cells almost a quarter of the expressed mRNAs enrich in neurites. Do they localize in other cell types of these vertebrates and if so how and where? Might they be expressed at exceptionally high levels? Do localized mRNAs across species share gene features similar to the ones we uncovered in *Drosophila*? These are questions of general interest provoked by our genome scale resource and its analysis. Additionally, numerous studies have attempted to use bioinformatics to predict mRNA localization signals with limited success. Our dataset breathe new life into those studies. At the same time our integrative analysis proposes that sequence independent mechanisms may play a role in localization of the major localization classes. *Thus we provide information that is essential for the RNA localization field in general.* Systematic and global approach will necessarily be descriptive and cannot provide the deep mechanistic understanding that a paper on the localization of one mRNA could grant. However, we believe that our global analysis of mRNA expression and localization in flies will benefit research in many areas beyond fruit fly oogenesis and propose new avenues of research that go beyond the established paradigms. As scientists we believe that large-scale resources are useful, enable novel insights into how genomes build cells and organisms and provide the raw material for in depth mechanistic studies. Therefore we would like to ask you to reconsider our submission as a Tools and resources article.

Reviewer \#1:

*1) What criteria did the authors use to determine the minus and/or plus end microtubule localization? For example, in the subsection headed "Changing mRNA localization during development" the authors state that 591 mRNAs co-localized with the microtubules minus ends during oogenesis. In the same subsection, they mention that "minus-end accumulation only re-emerged after initiation of transcription...". How did the authors test this localization with the microtubules? The authors should clearly write whether this type of co-localization was assumed for the mRNAs tested based on previous reports or provide data showing this finding. Would it not be better and less confusing to call the localization as "anterior" or "posterior"? It would tell the same story without implying additional mechanisms of localization, which were not tested at all*.

Categorization of mRNA localizations:

We thank both reviewers for requesting clarification on the categorizations of mRNAs with respect to overall cell polarity. We have substantially improved the explanations for the categories given in the text, included missing references to previous work detailing the organization of microtubules during oogenesis and substantially improved the figures to increase clarity (e.g. by including schematic diagrams and simplifying the critical figures; see [Figure 6B,C](#fig6){ref-type="fig"} and [Figure 6--figure supplement 1A, B](#fig6s1){ref-type="fig"}). For example, we have added the following excerpt to the "Global changes of mRNA location during development" subsection: "The oocyte has a highly polarized microtubule cytoskeleton that undergoes dramatic re-polarizations across oogenesis \[...\] the oocyte enriched, anterior and posterior localizations categories correspond to where the microtubule minus and plus ends are enriched ([@bib60]; [@bib35])".

The rationale for our categorization was to allow us to compare cell types from different developmental stages of the fly. Only through such categorization we can proceed to integrate the two large-scale datasets on RNA localization (our data and Lecuyer, 2007). The microtubule system is a very useful "universal coordinate system". An alternative would have been the cell polarity. Both the microtubule organization (e.g. reviewed in [@bib58]) and the cell polarity (e.g. reviewed in Suzuki and Ohno, 2006) have been well described in germline, follicle and embryonic cell types.

Why did we choose the microtubules? mRNAs in higher eukaryotes are most often transported along the microtubule cytoskeleton. In flies mRNA transport in the germline, somatic follicle cells, salivary glands and embryonic cells is equivalent. The same RNA localization signal can promote localization and the protein machinery that recognizes this "zipcode" signal is widely expressed (Bullock, 2001; Jambor, 2014).

Why did we not use the terms anterior/ posterior? Reason 1: the cytoskeleton is heavily repolarized during oogenesis. This creates the following terminological problem: mRNAs transported to microtubule minus ends at stage 2--7 would be labeled posterior, while the same transport step at stage 9--10 would be labeled anterior. Reason 2: not all cells that we analyzed localize mRNAs along the anterior--posterior axis: the somatic follicle cells and embryonic blastoderm cells (stage 4--5) localize most mRNAs along the apical-basal cortex (where "dorsal-ventral" localization would be the closest body polarity equivalent).

The reviewer also writes: "For example, in the subsection headed "Changing mRNA localization during development"*,* the authors state that 591 mRNAs co-localized with the microtubules minus ends during oogenesis." The exact quote the reviewer is referring to is: "During *early* oogenesis, the majority of mRNAs (n = 591) co-localized with microtubule minus ends...".

Thus, we do not claim these mRNAs are co-localized with microtubules during the entire oogenesis; in case the reviewer is questioning the use of the word "co-localization" in this sentence, we would like to point out that we did describe the relationship of RNAs and microtubules earlier in the manuscript, in the Results, as follows:

"The largest group, 591 mRNAs, was enrichment in the oocyte portion of the syncytial egg-chamber during early oogenesis (*fwe, Imp, Shroom*). At this stage the microtubule minus ends of the polarized microtubule cytoskeleton are also concentrated in the oocyte (reviewed in [@bib58])." Nevertheless, to be absolutely clear we have now changed the sentence to: "... during early oogenesis, the majority of mRNAs are in the minus category".

In general we believe that the link between the organization of microtubule cytoskeleton and mRNA localization in oogenesis is so well established that it warrants the use of microtubule polarity as a proxy for comparison of RNA localization events across time and tissues.

The reviewer also writes: "In the same subsection, they mention that 'minus-end accumulation only re-emerged after initiation of transcription...'". How did the authors test this localization with the microtubules?" This sentence refers to the section describing our global comparisons of mRNA localization across several datasets. We state at the beginning of the section that:

*"*To address this question we use again the microtubule polarity as a universal proxy of cell polarity \[...\]. This grouping enables us to compare localization of mRNAs between life cycle stages (ovaries and embryos) and cell types (germline and epithelial cells)."

Thus, this is an integrative analysis including published data from the Krause lab (Lecuyer, 2007) and no specific experiments testing microtubule association are involved. To be very clear we now only state that:

"This revealed that only very few of the minus and plus category mRNAs remained localized in embryogenesis: only 3 of the minus category mRNAs and a few more in the plus category. The plus category increased slightly at stage 1--3 of embryogenesis as a few ubiquitous oogenesis transcripts became localized. A rise of mRNAs in the minus category was only detectable at stage 4--5 of embryogenesis (apical localization) when the initiation of zygotic transcription occurs."

We have removed the speculative interpretation from the manuscript altogether. We have also included a clear description of the categories (see above, see [Figure 6--figure supplement 1B](#fig6s1){ref-type="fig"}) and made a clear reference which data is from [@bib40].

Nevertheless, mRNA enrichment at the apical cortex in stage 4--5 embryos has been shown to be a Egl-BicD-Dynein and microtubule-dependent process (Bullock, 2001; Wilkie and Davis, 2001; Dienstbier, 2009). We therefore again argue that the co-occurrence of predominant localization sites (i.e. apical in epithelia and posterior in oocyte) with overall polarity of microtubules allows us to use this association as means to compare equivalent localization sites across tissues.

*2)* [*Figure 2--figure supplement 1D*](#fig2s1){ref-type="fig"}*: the authors conclude that the "minus-end accumulation only re-emerged after initiation of zygotic transcription of the embryo, pointing to a potential link between transcription and minus-end localization of mRNAs". This Figure is misinterpreted as the authors neglect the fact that approximately 60% of the maternally-deposited genome is degraded in the embryo while the germ plasm enriched mRNAs are protected from degradation and remain enriched at the posterior. Thus, in this case degradation will affect the statistics in* [*Figure 2--figure supplement 1D*](#fig2s1){ref-type="fig"} *and the conclusion that there is a link between transcription and minus-end localization will not be valid. For example, the localization of Hsp83 mRNA at the posterior pole becomes apparent only after the activation of zygotic genome due to the degradation of un-localized Hsp83 elsewhere in the embryo. Did the authors find Hsp83 as "minus-end" localized in the stage 3-5 embryos? There are many mRNAs that localize to the posterior in a manner like Hsp83 and thus for them too this link between the minus end localization and transcription would be invalid. The authors should correct this error. Since the authors cannot account for the changes in mRNA levels due to mRNA degradation in the embryo this Figure is inherently difficult to interpret and should perhaps be removed from the manuscript*.

We do not show statistics in [Figure 2--figure supplement 1D](#fig2s1){ref-type="fig"}, we simply show a clustering of oocyte localized mRNAs and their subsequent distributions in early embryogenesis. This dendrogram only shows mRNAs that were localized in the oocyte and follows what happens to those mRNAs during stage 1--3 and stage 4--5 of embryogenesis. Consequently, many mRNAs that we either did not screen for or showed not oocyte localization will per definition not be shown in this graph, regardless of their localization mechanism. In fact, Lecuyer et al. showed many mRNAs in pole cells that we do not find to localize during oogenesis and thus apparently affects mRNAs other than the oocyte-localized mRNAs.

As described in the above section, we have now revised the figure structure, and clarified and improved the nomenclature. To avoid confusion, we have altogether removed the sentence: "Minus-end accumulation only re-emerged after initiation of zygotic transcription of the embryo, pointing to a potential link between transcription and minus-end localization of mRNAs."

Regarding the localization of Hsp83/localization through mRNA degradation: we hope from the revised figures ([Figure 6](#fig6){ref-type="fig"}) that it becomes clear that posterior localization is included in the "plus category", therefore Hsp83 would in our case not be in the minus category. Since the in situ in the ovaries gave no signal, the gene is entirely eliminated from the comparison of mRNAs across development. mRNA degradation of maternal transcripts occurs in two phases (Bashirullah, LIpshitz, 1999), one in the late oocytes during oocyte activation and a second phase during early embryogenesis at stage 2--3. The latter degradation pathway is mediated by SMG and does affect for example Hsp83 mRNA (Semotok, Smibert, 2005). To investigate how the many SMG-bound mRNAs (Chen, 2014) relate to oocyte localized mRNAs is very interesting. Due to the degradation/protection-from-degradation these mRNAs are enriched in the pole cells; this is an asymmetric distribution of the mRNA along the embryo, but not strictly a subcellular localization since the mRNAs is ubiquitous in pole cells and absent from the rest of the embryo. We did not include pole cell enrichment into any of our categories.

We now say: "To address this question we use again the microtubule polarity as a universal proxy of cell polarity \[...\]. This grouping enables us to compare localization of mRNAs between life cycle stages (ovaries and embryos) and cell types (germline and epithelial cells)".

The increase of "minus-end accumulation" that we now refer to as minus-category results primarily from apical accumulation of mRNAs in stage 4--5 of embryogenesis. These localizations arise at a time-point well beyond the SMG-mediated mRNA degradation and to our knowledge this apical mRNA localization has never been shown to result from mRNA degradation. We simply observed that an increase in the number of mRNAs in the minus category was only seen after the onset of zygotic transcription, and due to the timing (at stage 4--5), we can rule out that these are still maternal transcripts that suddenly localize again. This is a very interesting observation that could be of fundamental importance when considering how, when and where transport granules are assembled and re-modelled.

To be clear, we now say: "The plus category increased slightly at stage 1--3 of embryogenesis as a few ubiquitous oogenesis transcripts became localized. A rise of mRNAs in the minus category was only detectable at stage 4--5 of embryogenesis (apical localization) when the initiation of zygotic transcription occurs."

*3) In the subsection "Posterior localizations depend on oskar mRNA", the authors identified novel mRNAs enriched at the posterior, which in the absence of osk protein are no longer localized at the posterior pole. However, instead of interpreting this finding as an indication that* Oskar *protein and other germ plasm components are required for the posterior localization of these RNAs, the authors interpret this finding that these novel mRNAs hitchhiked with osk mRNA to the posterior or that oskar mRNA could recruit and stabilize minus ends at the posterior thereby enabling localization of these novel mRNAs. It would have been very exciting if the authors had identified another RNA besides osk itself that could hitchhike with osk or identified a new posteriorly localized RNA that directly, and independently of* Oskar *protein, requires microtubules for its localization. However, apparently none of their RNAs fit this interpretation, as judged by* [*Figure 3*](#fig3){ref-type="fig"}*, where the authors show that localization of all RNAs tested is affected in* osk84/Df*, where, as the authors also show, osk RNA is properly localized. More stringent experiments would have been to determine this question in an* osk166 *allele, a missense mutation (rather than the 84 nonsense allele) that affects germ plasm assembly, or other mutations downstream of Oskar that act in the germ plasm assembly pathway (Vasa, Tudor). The most definitive experiment would have been to ask whether these posteriorly localized RNAs localize to the anterior pole in oocytes and embryos expressing osk-bcd3\'UTR, since in this case osk RNA localization is clearly separated from its function in germ plasm assembly*.

*A more likely interpretation of their result is that Oskar and the assembled germ plasm entraps the other mRNAs enriched at the posterior, as proposed previously for the posteriorly localized RNA nanos (Curr Biol. 2003 July 15;13(14):1159-68). Furthermore, there is to my knowledge no published report that suggests that Oskar has a direct an effect on microtubule polarization. Thus the fact that localization of all RNAs is affected in the oskar RNA and protein null mutants, where microtubule polarity is normal, strongly suggests that these RNAs are not directly localized by microtubule mediated transport*.

We thank the reviewer for pointing out the unclear description of the genetic experiments. We show that posterior localization is impaired in several mutant egg-chambers that also affect *oskar* mRNA localization and have clarified our conclusions concerning *Stau*, *Btz* and *Spire* egg chambers (see below).

We also present data analyzing mutant combination that lacks Oskar protein but the *oskar* RNA is produced. In these *osk84/Df(3R)* egg-chambers without Oskar protein, *oskar* mRNA is normally localized at stage 9 but from stage 10 onwards becomes successively detached resulting in no RNA being localized anymore in the embryo. Similarly, the candidate posterior mRNAs also localize at stage 9 but from state 10 onwards their posterior levels are reduced or entirely absent (this obviously depends on the initial amount of posterior mRNA e.g. compare the wildtype levels of *vkg* (very high) versus *PI3K21* (low at 9). We therefore conclude that the candidate posterior mRNAs initially localize in the absence of Oskar protein but, like *oskar* mRNA, their localization is reduced from stage 10 onwards. In other words, posterior localization at stage 9 does not require Oskar protein.

In contrast, in egg-chambers that produce no posterior *oskar* mRNA (*oskA87/Df(3R)*), all candidate posterior mRNAs entirely fail to localize at stage 9 and beyond. We therefore conclude that their initial localization at the posterior pole does requires *oskar* mRNA. From our initial experiments it is unclear if this is a direct or indirect effect of *oskar* mRNA. (The notable exception, which we now also discuss in more detail in the manuscript, is *zpg* mRNA. This mRNA belongs to the group of mRNAs reaching the posterior pole only at late stage 9/stage 10. In this case we can't conclude whether *zpg* mRNA requires *oskar* mRNA or protein).

To increase the clarity of our genetic experiments, we have now:

a\) Created several paragraphs: one solely on the analysis of *Stau*/*Btz*/*Spire* mutant egg chamber and a separate section on *oskar* mutants (Protein, RNA; see subsection headed "Global features of localized mRNAs").

b\) We also included stage 9 and stage 10 data for the Oskar protein mutant egg-chambers; this clearly shows the stage 9 localization of candidate mRNAs at the posterior pole (see [Figure 3--figure supplement 5B](#fig3s5){ref-type="fig"}). We also explain the experiments and conclusions more clearly in the manuscript. We now state: "In these Oskar protein deficient egg-chambers *oskar* mRNA is initially localized \[...\] independent from Oskar protein."

c\) Finally, we moved the figure to the Supplementary material, since we feel it is not the most critical aspect of the paper; it merely provides initial interesting observations about possible mRNA transport mechanisms. We agree with the reviewer that additional experiments would be required to clarify the mechanism of localization of these mRNAs. By de-emphasizing our initial observations we hope to shift the focus of the paper back to genomics as initially intended.

Since Oskar protein is not required for initiating candidate RNA localization at the posterior pole, proteins downstream of Oskar, such as Vasa and Tudor, are also unlikely to have a direct effect on initiating localization at stage 9.

We agree that the *osk-bcd* experiment would be interesting; it would be particularly valuable to investigate specifically the mechanisms that localize mRNAs at the posterior pole from stage 10 onwards. We would speculate that these RNAs do require factors present in the germ plasm. However, to understand if *oskar*-RNA mediated localization at stage 9 is direct or indirect the experiment would be difficult to interpret. *osk-bcd* is expressed as a transgene in the presence of wild-type *oskar* mRNA. Thus the egg-chambers will have *oskar* mRNA at both poles. Depending on which portion of the oskar mRNA would mediate the interaction with the candidate mRNAs, they would be recruited to the both poles (motif in the CDS) or just the posterior pole (motif in the UTR, as shown for *osk--osk* hitchhiking). Finally, genetic evidence suggests that *osk* mRNA is able to recruit Par1 protein and in *osk-bcd* egg-chambers indeed Par1 accumulates at both poles of the oocyte (Shulman, 2000). This strongly influences the polarity of the entire egg-chamber and would make interpretation of the results difficult. In fact, a positive feedback loop between oskar mRNA/Oskar, Par1 and microtubule plus ends was previously shown (Zimyanin, 2007). In Btz and Khc mutants that are unable to promote *oskar* mRNA localization to the posterior pole this leads to a complete loss of posterior Kinesin-beta-Gal. Conversely, ectopic localization of *oskar* mRNA ultimately results in ectopic accumulation of Par1 and also microtubule plus ends, this was shown by Zimyanin et al., 2007 (Curr Biol. 2007 February 20;17(4):353-9.).

We have now removed our interpretative statement from the Results section and only state that: "We propose that the novel candidate mRNAs require *oskar* mRNA to initially reach the posterior pole and Oskar protein to remain stably anchored at the posterior pole beyond stage 9."

*Failure to localize after colcemide treatment is likely a function of loss of oskar localization*.

We do not think that from this experiment it is possible to conclude about direct effect of MTs on localization. And we did not and do not do so in the manuscript.

*It is thus misleading by the authors to interpret the defect in RNA localization after colcemide treatment as evidence for a direct role of microtubules in localization of these RNAs. The authors need to correct this misinterpretation of the data. Additional experiments such as careful analysis of the timing of RNA localization and disruption of the microtubule and actin cytoskeleton at different time points during oogenesis (see Curr Biol. 2003 July 15;13(14):1159-68) would be required to make any conclusions about the mechanisms of localization employed by the described RNAs. As these experiments are likely beyond the scope of the present analysis, the authors should avoid misleading readers*.

It is unclear what the reviewer is exactly commenting on. In the submitted manuscript we said:

"Transport of mRNAs towards the anterior and the posterior pole of the oocyte requires an intact microtubule cytoskeleton; accordingly, the localization of all new anterior and posterior candidate mRNAs is lost in colchicine treated egg-chambers, while ubiquitously distributed mRNAs or RNA foci in the nucleoplasm, that lacks a microtubule cytoskeleton, were unaffected by the colchicine treatment".

We now merely state that: "...We observed that the localization of all new anterior and posterior candidate mRNAs is lost in colchicine treated egg-chambers, while ubiquitously distributed mRNAs or RNA foci in the nucleoplasm, that lacks a microtubule cytoskeleton, were unaffected by the colchicine treatment ([Figure 3--figure supplement 4A-C](#fig3s4){ref-type="fig"}, Supplementary Table 8). "

Thus, we do not state that this is a direct effect. Our conclusion from these experiments, as stated in the paper, is simply that microtubules are involved and mRNA localization is lost in colchicine egg chambers. We do not state that microtubules have a direct role.

Minor comments:

*In the subsection "Widespread mRNA localization in ovaries", the authors cite the work by Saunders and Cohen to say that the oocyte nucleus is transcriptionally active. Unfortunately, these results were shown to be incorrect by Schupbach and colleagues in Dev Biol. 2000 May 15;221(2):435-46. In this manuscript Schupbach et al. show that the construct used by Saunders and Cohen included 5\'UTR sequences, which are required for localization of grk RNA to the nucleus (see also: Development. 2005 May;132(10):2345-53). To my knowledge there is not a single example that suggests that the oocyte nucleus is transcriptionally active at this stage*.

In our conclusion, we raised two possible explanations: either the nucleus is active or the mRNAs are imported into the nucleus at stage 9. There is no evidence whatsoever for RNAs being imported into the oocyte nucleus and nuclear envelope breakdown is not supposed to occur until stage 13 of oogenesis. However, we did observe mRNAs in the oocyte nucleus. There at least have been some investigations into transcription in the oocyte nucleus and this has been subject to much debate. We agree with the reviewer that there is no good evidence so far that there is transcription from the oocyte nucleus, which is arrested in meiotic prophase and condensed into a karyosome. However, as far as we know there is also no evidence ruling out any transcription. In fact, the paper cited by the reviewer clearly states that they do not exclude the possibility that mRNAs, including *gurken*, are transcribed in the oocyte nucleus; however this is not contributing to axis formation: "while our data do not exclude the oocyte nucleus as a potential additional source of *grk* transcripts, any such contribution is not required for axis determination" (Caceres, 2005)*.*

Thus, our observation that there are many mRNAs in the oocyte nucleus (note: we did not detect *grk* mRNA in the nucleus, but interestingly *rho* which genetically interacts with *grk*) simply adds an interesting observation to this long-standing debate.

Nevertheless, for increased clarity we have now state in the Results section: "191 RNAs were detectable specifically in ovarian nuclei mostly of the endocycling, polyploid nurse cells, but also in epithelial cells and in 29 cases in the oocyte nucleus ([Figure 2C,D](#fig2){ref-type="fig"}). The RNAs in ovarian nuclei were visible from stage 9 of oogenesis onwards and their localization changed appearance from stage 9--10 ([Figure 2--figure supplement 1B](#fig2s1){ref-type="fig"})." And, in the Discussion: "Curiously at stage 9 and 10 we also identified mRNAs enriched in the nuclei of the oocyte. These mRNAs could either be nurse cell transcripts imported into the meiotic oocyte nucleus or else the controversial instances of transcription from the meiotic nucleus ([@bib50]; [@bib9])."

Reviewer \#2:

*This manuscript presents a large scale* in situ *hybridization analysis of transcripts expressed during Drosophila oogenesis. The data are of high quality and provide a valuable complement to a previous study of mRNA localization patterns in the early Drosophila embryo. However, the analysis is almost entirely descriptive, the results are often not particularly informative, and conclusions are largely speculative*.

In particular, it isn\'t clear why the authors find it so surprising that RNAs change localization status in different cell types and at different times. If the goal of mRNA localization is to localize proteins (or restrict their domains), it stands to reason that local requirements for the encoded proteins may be more relevant in certain cell types (e.g. oocyte versus epithelial cells) and at certain developmental times.

Singular mRNAs can indeed be localized and non-localized: *std* mRNA is expressed in two isoforms, only one of them encompassing a localization signal (Horne-Badovinac, 2008). *Pgc* mRNA is initially localized at the anterior pole and then changes to a posterior localization (Nakamura paper), however the mechanism is entirely unclear. Only for one mRNA, *oskar,* the mRNA regions directing opposing microtubule localization is understood in more detail (Ghosh, 2012; Jambor, 2014). To our knowledge, however, there is no study yet showing that mRNAs do change their specific subcellular localizations to the dramatic extent that we observed. In contrast, it is generally believed that mRNAs have cis-regulatory localization signals (zipcodes) that dictate their intracellular transport. Previous studies showed that specifically the cell types compared in this study express the machinery required for mRNA localization and can localize a zipcode-containing reporter to equivalent subcellular sites ([@bib6]; Jambor, 2014). Zipcodes are sequences and integral parts of the mRNAs, similar to domains in a protein. Thus once an mRNA is expressed and the machinery is present, the zipcode should be recognized and the mRNA transported. We show that the mRNAs expressed in the oocyte show no sign of transcriptional and isoform variation during oogenesis. It follows that they should have the same motif throughout oogenesis that should promote localization. And yet, this is not the case. We were expecting to find mRNAs localized during oogenesis to show similar localization behavior in embryos. There was no published evidence that changing destinations in the cytoplasm is a global feature of mRNAs. We used the word surprising exactly once in the discussion part of our manuscript. We ask the reviewer whether disagreement on the subjective evaluation of the intuitive appeal of the data is a sound basis for dismissing a product of three years of work that generated large amounts of clearly useful data.

Previous studies describing large-scale mRNA localization were performed mainly at one time-point or in one subcellular compartment ([@bib52]; Blower et al., ; 2007; [@bib68]; [@bib10]) or following mRNAs distributions during embryogenesis, which to a large degree describes changes in cellular expression patterns rather than changes in subcellular localization ([@bib40]). We present the first integrative analysis of mRNA localization across cell types and developmental contexts. Surprising or not the results are what they are.

We believe that this data is important because it will strongly influence the analysis of mRNA regulation mechanisms. It will alter the way we think about zipcodes and initiate research into how they could possibly be regulated, e.g. by masking of zipcodes through proteins or by changing RNA secondary structures.

*In addition, I\'m not convinced that what the authors consider to be changes from microtubule minus-end to plus end localization or* de novo *plus end localization isn\'t simply a result of transcripts becoming anchored to the posterior cortex, such that they remain there despite changes in microtubule organization*.

mRNAs showing de novo enrichment (either stage 9 or stage 10) show no sign of localization during early oogenesis (see [Figure 6C](#fig6){ref-type="fig"}, stage 2--7, stage 8 of oogenesis). We cannot rule that indeed there is a tiny pool of mRNAs at the posterior pole that serves as a nucleation site for downstream localization. This initial amount of RNA enrichment however would be below the detection limit of light microscopy. mRNAs that change localization from oocyte enrichment (minus-end transport step, stage 2--7) to posterior accumulation at stage 9/10 are present in high concentrations in the oocyte. The fact that we cannot observe them at stage 8 of oogenesis at the posterior cortex argues against them simply remaining at the posterior cortex while the microtubule cytoskeleton is being re-organized.

*Alternatively, what appears as* de novo *plus-end localization may actually be due to association of those transcripts with the nascent polar granules organized by Oskar protein, rather a specificity for microtubule plus ends. And the further increase in plus-end localization during embryogenesis does not result from a favoring of plus-end accumulation over minus-end accumulation in the embryo, but rather from the well-documented protection from degradation afforded by the germ plasm*.

As the reviewer correctly points out, the de novo localization, that resembles for instance *nanos* mRNA localization, could indeed be posterior recruitment by the pole plasm components. We believe our shortcoming to explicitly state how we define "plus" and "minus" in the figure lead to confusion. We do not wish to claim that posterior localization at stage 10 and beyond is driven by directed microtubule movement; in fact, with the onset of cytoplasmic streaming this will most likely be impossible. We simply used "plus" to define a category of mRNA localizations.

We have now included schematics ([Figure 6B,C](#fig6){ref-type="fig"}), simplified the figure and explicitly stated how we categorized "minus" and ''plus" in the [Figure 6B](#fig6){ref-type="fig"} (inset) and in the text as opposed to merely in the Supplementary Table. We state that: "In order to compare localizations across oogenesis stages we categorized the localized mRNAs as being in proximity to microtubule minus- or plus- ends (plus and minus category [Figure 6B](#fig6){ref-type="fig"}, inset). We do not show direct association of all localised mRNAs with microtubules. However, microtubule cytoskeleton is required for RNA localization ([@bib58]) and the oocyte enriched, anterior and posterior localizations categories correspond to where the microtubule minus and plus ends are enriched ([@bib60]; [@bib35])."
